Physical capacity and supplementation of vitamin D and calcium in postmenopausal women by Kärkkäinen, Matti
Publications of the University of Eastern Finland
Dissertations in Health Sciences
isbn 978-952-61-0309-9
Publications of the University of Eastern Finland
Dissertations in Health Sciences
In general, the fracture risk is 
highest among those who have 
osteoporotic bone mineral density 
(BMD) but nonetheless most fragility 
fractures occur in subjects who do 
not have osteoporosis. Their poor 
physical condition might predispose 
these individuals both to low BMD 
and a higher risk for fall-related 
fractures. Vitamin D has been 
shown to have also physiological 
importance outside of bone health 
and calcium homeostasis, and there 
is evidence that it plays a role in the 
prevention of falling.
The present thesis was based on 
Kuopio Osteoporosis Risk Factor 
and Prevention study (OSTPRE) 
and its substudy OSTPRE Fracture 
Prevention Study (OSTPRE-FPS).
d
issertatio
n
s | 039 | M
atti K
ä
r
k
k
ä
in
en
 |  P
hysical C
ap
acity and S
upplem
entation of V
itam
in
 D
 an
d C
alciu
m
 in
 P
ostm
en
op
au
sal W
om
en
Matti Kärkkäinen
Physical Capacity
and Supplementation of
Vitamin D and Calcium in
Postmenopausal Women
Matti Kärkkäinen
Physical Capacity and Supplementation 
of Vitamin D and Calcium in
Postmenopausal Women
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATTI KÄRKKÄINEN 
 
 
 
Physical Capacity and Supplementation of Vitamin D and Calcium in 
Postmenopausal Women 
 
 
 
 
 
 
 
 
To be presented by permission of the Faculty of Health Sciences, University of Eastern 
Finland for public examination in the Auditorium L22, Snellmania, University of Eastern 
Finland, on Saturday 29th January, at 12 noon 
 
Publications of the University of Eastern Finland 
Dissertations in Health Sciences 
39 
 
Bone and Cartilage Research Center (BCRU), University of Eastern Finland (Kuopio) 
Department of Orthopaedics, Traumatology and Hand Surgery, Kuopio University Hospital 
Kuopio 2011 
 
 
 
 
 II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kopijyvä Oy 
Kuopio, 2011 
 
Editors: 
 
Professor Veli-Matti Kosma, M.D., Ph.D. 
Department of Pathology, Institute of Clinical Medicine 
School of Medicine, Faculty of Health Sciences 
 
Professor Hannele Turunen, Ph.D. 
Department of Nursing Science 
Faculty of Health Sciences 
 
Professor Olli Gröhn, Ph.D. 
 A. I. Virtanen Institute for Molecular Sciences 
  Department of Neurobiology  
University of Eastern Finland 
 
Distribution: 
University of Eastern Finland Library / Sales of Publications 
P.O. Box 1627, FI-70211 Kuopio, Finland 
http://www.uef.fi/kirjasto 
 
ISBN: 978-952-61-0309-9 (print) 
ISSN: 1798-5706 (print) 
ISSNL: 1798-5706 
ISBN: 978-952-61-0310-5 (pdf) 
ISSN: 1798-5714 (pdf) 
 
 
 
 III 
 
 
 
 
 
 
 
Author’s address  Bone and Cartilage Research Unit 
   University of Eastern Finland 
   P.O. Box 1627 
   70211 Kuopio, Finland 
   e-mail: matti.karkkainen@uef.fi 
 
Supervisors:  Professor Heikki Kröger, M.D., Ph.D. 
Department of Orthopaedics, Traumatology and 
Hand Surgery 
Kuopio University Hospital 
Kuopio, Finland 
e-mail: heikki.kroger@kuh.fi 
 
Professor Jukka Jurvelin, Ph.D. 
Department of Physics 
University of Eastern Finland 
Kuopio, Finland 
e-mail: jukka.jurvelin@uef.fi 
 
Reviewers:  Professor Ari Heinonen, Ph.D. 
Department of Health Sciences 
University of Jyväskylä  
Jyväskylä, Finland 
e-mail: ari.heinonen@jyu.fi 
 
Professor Timo Möttönen, M.D., Ph.D. 
Rheumatology Unit 
Department of Internal Medicine 
Turku University Hospital 
University of Turku 
Turku, Finland 
e-mail: timo.mottonen@tyks.fi 
 
Opponent:  Docent Jari Salo, M.D., Ph.D. 
  Department of Orthopaedics and Traumatology 
  Helsinki University Central Hospital 
  University of Helsinki 
  Helsinki, Finland 
   e-mail: jari.salo@hus.fi 
 
 
 IV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 V 
Kärkkäinen, Matti. Physical capacity and supplementation of vitamin D and calcium in postmenopausal 
women. Publications of the University of Eastern Finland. Dissertations in Health Sciences 39. 2011. 100p. 
ISBN: 978-952-61-0309-9 (print) 
ISSN: 1798-5706 (print) 
ISSNL: 1798-5706 
ISBN: 978-952-61-0310-5 (pdf) 
ISSN: 1798-5714 (pdf) 
 
ABSTRACT 
 
In general, the fracture risk is highest among those who have osteoporotic bone mineral density (BMD) but 
nonetheless most fragility fractures occur in subjects who do not have osteoporosis. Their poor physical 
condition might predispose these individuals both to low BMD and a higher risk for fall-related fractures.  
 
Vitamin D has been shown to have also physiological importance outside of bone health and calcium 
homeostasis, and there is evidence that it plays a role in the prevention of falling and it has been associated 
with a wide spectrum of diseases. 
 
The present thesis was based on Kuopio Osteoporosis Risk Factor and Prevention study (OSTPRE) and its 
substudy OSTPRE Fracture Prevention Study (OSTPRE-FPS). Physical capacity tests and fracture 
validation were performed on the OSTPRE cohort (n=2928). The OSTPRE-FPS was an open-label RCT with 
a 3-year duration conducted during 2003-6. The OSTPRE-FPS population of 3,432 women was randomly 
selected from the population-based OSTPRE cohort. The women were randomized into two groups of equal 
size. The intervention group (n=1,718) obtained daily cholecalciferol 800 IU and calcium carbonate 1000 mg 
supplementation divided into two daily doses for three years and the control group (n=1,714) received no 
supplementation. The physical capacity tests and BMD measurements were performed in a pre-defined 
subsample of 750 women. In addition, falls were self-reported from the entire trial population (n=3432). 
 
It was shown that functional capacity was decreased in women with femoral neck osteoporosis (WHO 
classification) compared to women with normal or osteopenic BMD: standing-on-one-foot (SOOF) !39% 
(p=0.001), grip strength (GS) !18% (p<0.001), leg extension strength !19% (p=0.007) and ability to squat 
down on the floor !40% (p=0.004). Furthermore, the decreased GS, low leg extension strength, inability to 
perform SOOF 10 seconds and self-assessed ability to walk less than 100 meters were associated with 
future fractures. Accordingly, it was proposed that GS could be used in medical decision making to identify 
those women who would benefit from BMD measurements albeit alone it may not represent an accurate 
enough tool for osteoporosis screening. In addition, being unable to perform SOOF for 10 seconds, GS and 
a question about ability to walk less than 100 meters may help to predict postmenopausal fractures. It is 
speculated that the poor physical condition increased both the prevalence of low BMD and the risk for fall-
related fractures.  
 
The OSTPRE-FPS indicated that daily vitamin D 800IU and calcium 1000mg could decrease the risk of 
multiple falls requiring medical attention in a general population of women aged 65 to 71. In addition, vitamin 
D and calcium supplementation have a positive effect on the skeleton in women who have adequate 
nutritional calcium intake. These benefits were gained without any severe side effects from the 
supplementation. Accordingly, a higher vitamin D intake can be recommended for postmenopausal women 
aged 65 to 71. 
 
National Library of Medicine Classification: QU 173, QV 276, WE 180, WE 200, WA 288 
Medical Subject Headings: Bone Mineral Density, Calcium, Falls, Fractures, OSTPRE, Randomized 
Controlled Trial, Vitamin D 
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TIIVISTELMÄ 
 
Yleisesti ottaen murtumariski on suurin niillä henkilöillä joilla on osteoporoottinen luuntiheys. Kuitenkin suurin 
osa murtumista tapahtuu henkilöille, joilla ei ole osteoporoosia. Huono fyysinen kunto voi sekä altistaa 
alhaiselle luun mineraalitiheydelle että lisätä kaatumaperäisten murtumien riskiä. 
 
D-vitamiinia tarvitaan luuston terveyden ylläpitämiseen ja elimistön kalsiumtasapainon säätelyyn, mutta sillä 
on muutakin fysiologista merkitystä. On viitteitä siitä, että D-vitamiinin riittävällä saannilla on merkitystä 
kaatumisten ehkäisyssä. Sen puute on yhdistetty myös moniin sairauksiin. 
 
Tämä väitöskirja perustuu Kuopion Osteoporoosin vaaratekijät ja ehkäisy – tutkimukseen (OSTPRE) ja  sen 
alaiseen OSTPRE – murtumanesto tutkimukseen (OSTPRE-FPS). OSTPRE-väestöstä poimituille 2928 
naiselle tehtiin fyysiset toimintakykytestit ja murtumavalidaatio. OSTPRE-FPS oli kolme vuotta kestävä avoin 
randomoitu kontrolloitu tutkimus (vuosina 2003-2006) 3432 naiselle, jotka oli satunnaisesti valikoitu OSTPRE 
väestöotoksesta. Naiset satunnaistettiin kahteen samankokoiseen ryhmään. Interventioryhmä, johon kuului 
1718 naista, käytti kolmen vuoden ajan kahdesti päivässä D-vitamiini ja kalsiumvalmistetta. 
Vuorokausiannos sisälsi 800 IU kolekalsiferolia ja 1000mg kalsiumkarbonaattia. Kontrolliryhmän 1714 naista 
eivät saaneet täydennysvalmistetta. Ennalta määritellylle 750 henkilön oheisotokselle tehtiin fyysiset 
toimintakykytestit ja luuntiheysmittaukset. Kaatumiset olivat henkilöiden itsensä ilmoittamia koko 
tutkimusväestössä (n=3432). 
 
Naisilla, joilla oli reisiluun kaulan osteoporoosi, oli alentunut fyysinen toimintakyky verrattuna niihin, joiden 
luuntiheys oli normaali tai osteopeeninen. Kyky seistä yhdellä jalalla oli heillä alentunut -39% (p=0.001), 
puristusvoima -18% (p<0.001), alaraajan ojennusvoima -19% (p=0.007) ja kyky kyykistyä lattiaan asti -40% 
(p=0.004). Lisäksi naiset, joilla oli alentunut puristusvoima ja alhainen alaraajan ojennusvoima ja jotka eivät 
pystyneet seisomaan yhdellä jalalla kymmentä sekuntia eivätkä itse ilmoittamana kävelemään sataa metriä, 
saivat myöhemmin todennäköisemmin murtumia kuin muut. Näiden tulosten perusteella käden 
puristusvoimaa voidaan käyttää kliinisessä päätöksenteossa niiden henkilöiden tunnistamiseksi, jotka 
hyötyvät luuntiheysmittauksista, vaikka se ei yksin olekaan tarpeeksi tarkka osteoporoosin seulontaan. 
Lisäksi vaihdevuosien jälkeisiä murtumia voi ennakoida tutkimalla potilaan puristusvoimaa ja kykyä seistä 
yhdellä jalalla kymmenen sekunnin ajan sekä kysymällä, kykeneekö potilas kävelemään sata metriä. 
Voidaan olettaa, että huono fyysinen kunto lisää sekä alhaisen luuntiheyden yleisyyttä että kaatumisesta 
johtuvien murtumien riskiä. 
 
OSTPRE-FPS tutkimus osoitti, että päivittäinen 800 IU D-vitamiinia ja 1000mg kalsiumia sisältävän 
täydennysvalmisteen käyttö voi vähentää toistuvien hoitoa vaatien kaatumisten riskiä 65-71 – vuotiaassa 
naisväestössä. Lisäksi D-vitamiini- ja kalsiumlisällä on myönteinen vaikutus naisten luuntiheyteen, vaikka 
kalsiumin saanti olikin tutkimukseen osallistuneilla lähtökohtaisesti riittävä. Kalsium- ja D-vitamiinilisällä ei 
ollut vakavia sivuvaikutuksia. Tutkimuksen perusteella voidaan suositella korkeampaa D-vitamiinin saantia 
65-71 –vuotiaille naisille.  
 
National Library of Medicine Classification: QU 173, QV 276, WE 180, WE 200, WA 288 
Yleinen suomalainen asiasanasto: D-vitamiini, kaatuminen, kalsium, luu, luunmurtumat 
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1 INTRODUCTION 
 
In general, the fracture risk is highest among those who have osteoporotic BMD (Kröger 
et al. 1995, Pasco et al. 2006) but nonetheless over half of fragility fractures occur in 
subjects who do not have osteoporosis (Pasco et al. 2006, Sanders et al. 2006). Only in 
the population of age over 80 years does the majority of fractures occur in women with 
osteoporosis (Sanders et al. 2006). Accordingly, while the BMD is certainly one risk 
factor it is not the sole predictor for fractures. The importance of maintaining muscle 
strength to avoid bone loss has been emphasized (Sirola et al. 2006). In addition, poor 
balance and weak muscle strength of lower limbs have been associated with an 
increased incidence of falls (Tinetti et al. 1988, Nevitt et al. 1989, Dargent-Molina et al. 
1996). Thus, the poor physical condition might predispose to both low BMD and a 
higher risk for fall-related fractures. 
 
Each year, one third of individuals aged 65 or older will experience a fall (Campbell et 
al. 1981). Fall-related injuries require hospital admission in 42% of cases (Sattin et al. 
1990) and 6–23% of those falling will suffer serious injuries (Nevitt et al. 1991, Tinetti et 
al. 1995). Vitamin D is now known to be of physiological importance beyond its effects 
on bone health and calcium homeostasis, for example there is evidence that it plays a 
role in the prevention of falling and it has been linked with beneficial properties in 
combatting a wide range of diseases. 
 
Serum levels of 25-hydroxyvitamin D (25[OH]D) are directly related to BMD (Bischoff-
1
  
Ferrari et al. 2006). Low vitamin D status is prevalent in elderly women living in northern 
latitudes (Margiloff et al. 2001), but this deficiency can also be detected in young adults 
in northern Europe (Lamberg-Allardt et al. 2001) as well as in the housebound elderly 
living elsewhere (Gloth 3rd et al. 1995). Obviously this is a factor contributing to 
increased bone loss in the elderly.  
 
The aims of the present studies were to determine whether relatively simple and 
clinically applicable physical capacity tests could provide clinically relevant information 
for detecting postmenopausal women who have osteoporosis and further could they 
help identify those subjects who will experience a fracture. In addition, there is still no 
definitive answer if vitamin D and calcium supplementation are effective as improving 
bone status, in particular, there are no population-based trials to resolve this issue. 
Furthermore, there are no population-based trials concerning the effects of vitamin D 
and calcium supplementation on fall prevention. 
 
 
 
 
 
 
 
 
 
2
  
2 REVIEW OF THE LITERATURE 
2.1 Osteoporosis and bone strength 
 
Bone strength depends not only on the material properties but also on size, shape and 
three-dimensional architecture of the bone (Ahlborg et al. 2003). Bone has the ability to 
modify its composition and structure to accommodate prevailing loads (Seeman et al. 
2007). Areal bone mineral density (BMD) is a powerful determinant of bone strength 
(Kanis et al. 2008). The National Institutes of Health (NIH) has defined osteoporosis as 
a disease of increased skeleton fragility accompanied by low BMD and 
microarchitectural deterioration (National Institutes of Health 2001). Trabecular bone 
loss has been reported to begin in young adulthood and one can detect substantial 
cortical bone loss in midlife (Riggs et al. 2008). An accelerated trabecular bone loss 
occurs in the perimenopause (Riggs et al. 2004). It has been shown that in the upper 
end of femur, bone loss occurs uniformly throughout the femoral neck, leading to an 
overall decrease in femoral bone mass and trabecular thickness (Tanck et al. 2009). 
Secondary causes for osteoporosis, such as certain systemic diseases (Poole et al. 
2002) and medications (van Staa et al. 2002) as well as osteomalacia and malignancy, 
induce both bone loss and fractures.  
 
The clinical relevance of osteoporosis lies in the subsequent risk of fractures. Recovery 
from hip fracture is slow and often incomplete, with many patients being permanently 
institutionalised. Vertebral fracture, another common osteoporotic fracture, causes 
acute pain and loss of function (Kanis et al. 2008). Premature mortality following hip and 
3
  
vertebral fractures is well documented (Center et al. 1999, Cauley et al. 2000). 
 
2.2 Diagnosis and screening of osteoporosis 
 
Bone mineral density (BMD) is determined by both the peak bone density achieved 
during the growth period up to skeletal maturity and the subsequent bone loss related to 
age and menopause (Hui et al. 1990). Up to 70% of the variation of bone density is 
determined by heredity (Vicente-Rodriguez et al. 2007). Several gene sequence 
variants are associated with BMD and low trauma fractures (Styrkarsdottir et al. 2008). 
The diagnosis of osteoporosis is generally based on the assessment of BMD at the 
spine or the femoral neck by dual energy X-ray absorptiometry (DXA). The results 
obtained are interpreted according to the WHO definition of osteoporosis (i.e. a value for 
BMD 2.5 or more below the young adult mean). Measurements at the femoral neck 
have the highest prediction for hip fracture risk (Marshall et al. 1996, Johnell et al. 2005) 
but BMD measurements cannot identify subjects who will subsequently experience a 
fracture (Marshall et al. 1996). Femoral measurement has also of highest clinical 
relevance due to the morbidity associated with hip fracture (Melton III 2003). 
 
Non-selective, population-based screening for osteoporosis with DXA is not 
recommended (Kanis et al. 2005). Several decision rules, based on clinical criteria, for 
BMD referrals have been developed (Michaëlsson et a. 1996, Lydick et al. 1998, 
Cadarette et al. 2000, Weinstein et al. 2000). These decision rules are not meant to 
replace diagnostic tests, but to help to identify high-risk individuals that may benefit from 
4
  
BMD testing (McGinn et al. 2000). These risk assessment tools have been evaluated 
(Cadarette et al. 2000, Gourlay et al. 2008) but their suitability for case-finding 
approaches is controversial. However, BMD is only one of many factors that 
independently influences the fracture risk. WHO have introduced the fracture risk 
assessment tool FRAXTM that has been developed based on the use of clinical risk 
factors with or without BMD (Kanis et al. 2008). Its validation to predict hip fractures has 
shown that there is a strong positive correlation between predicted and observed ratios 
(Leslie et al. 2010). 
 
Osteoporosis and osteoporotic fractures are strongly associated with age (Boonen et al. 
2008). Indeed, elderly patients with a prevalent fragility fracture have been suggested to 
be in need of osteoporosis treatment, regardless of their BMD (Boonen et al. 2008). 
However, repeat low-trauma fractures constitute nearly one half of the fracture burden 
in women and this has been found to be independent of BMD (Langsetmo et al. 2009). 
Accordingly, the proposal to generalise osteoporotic treatment not only to the population 
of osteopenic but also with normal BMD is difficult to justify since only a few 
pharmacological interventions have any effect to prevent nonvertebral fractures 
(Chapurlat et al. 2006) and their antifracture efficacy could be even more questionable 
in non-osteoporotic subjects. The pharmacological interventions that are currently in use 
effect primarily on vertebral fracture prevention (Chapurlat et al. 2006). Other 
osteoporosis drugs have been introduced and these agents have a more anabolic effect 
on bone (Neer et al. 2001, Cummings et al. 2009). Currently the following drugs for 
osteoporosis treatment are available on prescription in Finland: alendronate, etidronate, 
5
  
risedronate, ibandronate, tsoledronate, estrogen, raloxifene, calcitonin, testosterone, 
strontium ranelate, teriparatide, parathyroid hormone (PTH) and denosumab.   
 
2.3 Falls 
 
One third of individuals aged 65 and older fall at least once each year and about half of 
these fall twice or more (Tinetti et al. 1988, Nevitt et al. 1989). The consequences of 
falling are severe; 3-6% of falls lead to a fracture (Tinetti et al. 1988, Stel et al. 2004), 
68% to a physical injury (Stel et al. 2004) and 12% cause a serious injury (Tinetti et al. 
1995). Falls are an important external cause for fractures to distal radius (Vogt et al. 
2002), proximal humerus (Kristiansen et al. 1987) and hip (Hayes et al. 1993). In fact, 
fall impact directly at the greater trochanter of the proximal femur increases the relative 
risk of hip fracture by as much as 30-fold (Hayes et al. 1993, Nevitt et al. 1993, 
Greenspan et al. 1998). However, only 25% of vertebral fractures result from falls 
(Cooper et al. 1992). 
 
Non-syncopal falls have complex and diverse causes. Maintaining an upright posture 
requires sensory input from the visual, tactile, proprioceptive and vestibular systems, 
central processing and a well coordinated motor response (Lord et al. 1994, Tinetti et al. 
1997). Further, ankle flexibility, plantar tactile sensation and foot muscle strength play 
major roles in balance in older individuals (Menz et al. 2005). The use of certain 
medications increases the likelihood of falling in elderly subjects (Woolcott et al. 2009). 
Falling is multifactorial caused by intrinsic and extrinsic risk factors, usually a 
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combination of factors (Graafmans et al. 1996). In addition, the fall mechanism leading 
to hip or wrist fracture is different from that in non-injurious falls (Nevitt et al. 1993). 
Patients who fall have impaired functional performance and psychomotor function 
(Dhesi et al. 2002). Falls that happen indoors have been associated with a subsequent 
functional decline (Manty et al. 2009). Furthermore, balance, gait, neuromuscular and 
cognitive impairment have been associated with a risk of experiencing a serious injury 
during a fall (Nevitt et al. 1991, Tinetti et al. 1995). In addition, subjects who have fallen 
and have early signs of mobility decline (Mänty et al. 2010), gait or balance problems 
(Ganz et al. 2007) or impaired physical and cognitive function (Formiga et al. 2008) are 
at an especially high risk of suffering subsequent falls. 
 
Earlier studies on multifactorial fall prevention in the elderly have shown both the 
positive (Tinetti et al. 2003, Kannus et a. 2005) and conflicting results (Gates et al. 
2008, de Vries et al. 2010). However, several single-intervention strategies for fall 
prevention have been proven to be beneficial. Strength and balance training can reduce 
the risk of both non-injurious and injurious falls (Campbell et al. 1997, Robertson et al. 
2001, Robertson et al. 2002, Day et al. 2002, Tinetti et al. 2003, Chang et al. 2004). 
However, the risk of falling may be increased in both the most physically active as well 
as the inactive persons (Moayyeri 2008), though this proposal could not be confirmed in 
a recent study (Peeters et al. 2010). On the other hand, walking and leisure-time 
physical activity have been shown to reduce the risk of subsequent hip fractures 
(Feskanich et al. 2002) and recurrent falling (Peeters et al. 2010). It has been 
postulated that recurrent fallers especially might benefit from prevention based on 
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mobility improvement (Graafmans et al. 1996). Vitamin D and calcium have been shown 
to reduce the risk of falls in ambulatory and institutionalized elderly subjects (Callagher 
et al. 2001, Bischoff-Ferrari et al. 2004, Bischoff-Ferrari et al. 2004, Harwood et al. 
2004, Larsen et al. 2005). In addition, withdrawal of psychotropic drugs (Campbell et al. 
1999), cataract surgery (Harwood et al. 2005) and home hazard assessment and 
modification (Gillespie 2009) have all been shown to reduce the risk of falling in the 
elderly. 
 
2.4 Fractures 
 
In women over the age of 60 years, the risk of fracture has been shown increase 6% 
per year of age (Pasco et al. 2006). Osteoporotic fractures have generally been defined 
as fractures that occur following relatively low trauma, such as a fall from standing 
height or less (Center et al. 2007). Fractures of the vertebrae, proximal femur and distal 
forearm have been regarded as the traditional osteoporotic fractures (Cummings et al. 
2002). Hip BMD has been associated with almost all types of fractures, an association 
that is stronger than with spinal or peripheral BMD (Stone et al. 2003). Low BMD has 
been associated with both the low and high trauma fractures (Mackey et al. 2007). 
However, less than one-half of fractures have been reported to be attributable to 
osteoporosis (Stone et al. 2003). The 5-year age-standardised absolute fracture risk 
has been shown to rise from 7% in persons who have normal BMD up to 47% in 
individuals who suffer osteoporosis and prevalent fracture (Pasco et al. 2006). In 
general, the fracture risk is highest among those who have osteoporotic BMD (Kröger et 
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al. 1995, Pasco et al. 2006) but most fragility fractures occur in subjects who are not 
suffering from osteoporosis (Pasco et al. 2006, Sanders et al. 2006). Postmenopausal 
women with the highest physical activity level also have a moderately higher wrist 
fracture risk despite their slower femoral bone loss (Rikkonen et al. 2010). In fact, risk of 
falling has been more closely associated with limb fracture risk than with BMD (Kaptoge 
et al. 2005). It has been postulated that the underlying mechanism of early 
premenopausal non-wrist fractures is an increased propensity to trauma rather than a 
low BMD value (Honkanen et al. 1997). In addition, neuromuscular impairment has 
been associated with both hip (Dargent-Molina et al. 1996) and proximal humerus 
fractures (Kelsey et al. 1992). The important risk factors for hip and wrist fractures 
apparently relate to bone strength and falls (Nevitt et al. 1993, McClung et al. 2001). 
 
The burden of osteporotic fractures relates to the morbidity and associated mortality 
(Cooper 1997, Center et al. 1999). In the first year following a hip fracture, 10-20% of 
patients die from its complications (Cummings et al. 2002). In contrast, distal forearm 
fractures do not elevate mortality rates (Cooper et al. 1993). The events surrounding the 
fracture are at least part of the cause of the excess mortality (Bliuc et al. 2009). The 
underlying health of the patient is closely related to mortality (Tosteson et al. 2007). In 
all, 50% of all low-trauma fractures have been reported to be nonhip and nonvertebral 
fractures, and to be associated with more than 40% of all deaths (Bliuc et al. 2009). If 
one focuses exclusively on hip fractures then there is the risk of underestimating the 
contribution of osteoporosis and the need for its management (Delmas et al. 2007). It 
has been concluded in meta-analyses that a previous fracture increases the risk for a 
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subsequent fracture by 2-fold, and a prior vertebral fracture increases the risk for 
subsequent vertebral fracture by 4-fold (Klotzbuecher et al. 2000, Kanis et al. 2004). A 
previous wrist fracture increases the risk for subsequent wrist fracture by 1.6-fold 
(Honkanen et al. 2000). It has been claimed that previous fragility fractures predict 
future ones (Lauritzen et al. 1993, Honkanen et al. 1997). In fact, half of women will 
experience another fracture in the following 10 years (Center et al. 2007). A subsequent 
fracture increases mortality risk by 3- to 4-fold (Bliuc 2009). In addition, the subsequent 
fracture might be a hip or other major fracture even though the initial fracture was only a 
minor one (Center et al. 2007).  
 
2.5 Physical capacity 
 
Regular physical activity is important in preserving acquired peak bone mass during 
puberty (Rautava et al. 2007). Resistance training affects positively the maintenance of 
regional femoral BMD (Ryan et al. 1998). In particular, the weight-bearing bones of the 
lower extremities benefit from long-term physical activity (Rikkonen et al. 2006). Muscle 
strength has been reported to account for 15-20% of the total variance in BMD in young 
women (Snow-Harter et al. 1990) and as much as 30% of the variability of total skeletal 
BMD can be explained by lean mass and the amount of physical exercise 
(Valdimarsson et al. 1999). Neuromuscular performance has been shown to 
independently associate with bone strength (Rantalainen et al. 2010). The association 
of grip strength with spinal (Sirola et al. 2005), femoral (Cauley et al. 2005) and forearm 
BMD (Bevier et al. 1989) might point to a systemic relationship between muscle 
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strength and BMD. In addition, grip strength is associated with bone loss (Sirola et al. 
2005) and future fractures (Sirola et al. 2006). However, changes in grip strength have 
not been found to be associated with changes in the radial BMD (Wang et al. 2004). 
 
Back extensor muscle strength and lumbar spine mobility have been found to be 
associated with quality of life in postmenopausal osteoporotic patients (Miyakoshi et al. 
2007). In a subsequent trial, back extensor strength exercise was found to improve the 
quality of life (Hongo et al. 2007). Poor lower-extremity performance is strongly 
predictive of future disability, hospitalization, and premature mortality (Guralnik et al. 
1995). In addition, hand grip strength has been found to predict functional limitations 
and disability in men (Rantanen et al. 1999) and frailty in older women (Syddall et al. 
2003). 
 
Physical activity and muscle strength have been shown to predict the severity of 
disability (Rantanen et al. 1999). Loss of strength in lower limb muscles (Macrae et al. 
1990) and ankle weakness are important factors contributing to poor balance (Whipple 
et al. 1987). The get-up and go test has been reported to be a reliable way to assess 
the balance of elderly patients (Mathias et al. 1986) and basic functional mobility 
(Podsiadlo et al. 1991). In addition, a poor tandem walk predicted recurrent falling in 
home-dwelling elderly fallers (Nevitt et al. 1989). Physical inactivity has been associated 
with increased risk for ankle and wrist fractures (Honkanen et al. 1998). In males, a high 
degree of leisure-time physical activity has been reported to be able to protect against 
hip fracture (Trimpou et al. 2010). It has been claimed that everyday physical activities 
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such as household work, walking, and gardening may play an important role in 
maintaining strength in older people at an adequate level to permit independent living 
(Rantanen et al. 1997). 
 
2.6 Role of vitamin D and calcium 
 
2.6.1 Vitamin D functions and considerations for sufficient daily dose 
 
Vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) are the two forms of vitamin 
D. In the skin, with the effect of ultraviolet B (UVB) radiation, 7-dehydrocholesterol is 
photoconverted to previtamin D3, which is further converted to vitamin D3 
(cholecalciferol). In the serum, vitamin D3 is bound to a vitamin D binding protein and 
transported to the liver, where it is hydroxylated to 25(OH)D3. In the kidneys, 25(OH)D3 
is further metabolized to 1,25-dihydroxyvitamin D3 [1,25(OH)D3] and this is a biologically 
active form of vitamin D3 (Dusso et al. 1998). It is known that the colon, prostate, breast, 
brain, !-islet cells, vascular smooth muscle cells and macrophages are able to produce 
1,25(OH)D3 (Schwartz et al. 1998, Cross et al. 2001, Holick 2007). Vitamin D3 can 
obtained from oily fish, fortified dairy products or supplements. Vitamin D3 has been 
shown to increase serum 25(OH)D level more efficiently than vitamin D2 (Trang et al. 
1998, Armas et al. 2004). The serum 25(OH)D concentration reflects both endogenous 
production and intake of vitamin D, and therefore it is clinically useful (Holick 2007). 
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Earlier vitamin D sufficiency was defined as the level of 25(OH)D sufficient to prevent 
rickets in children and osteomalacia in adults (Bikle et al. 2008). Currently, there is no 
clear definition of optimal vitamin D status. However, studies of the relationship between 
25(OH)D and BMD (Bischoff-Ferrari et al. 2004), fractures (Bischoff-Ferrari et al. 2005), 
lower extremity function (Bischoff-Ferrari et al. 2004), periodontal disease (Krall et al. 
2001) and colorectal cancer (Bischoff-Ferrari et al. 2006) have shown that a serum level 
of 75nmol/l or greater can be considered to be a sufficient vitamin D level (Dawson-
Hughes et al. 2005, Holick 2007). High rates of vitamin D deficiency have been reported 
in apparently healthy children (Lehtonen-Veromaa et al. 1999, Holick 2007), young 
adults (Gordon et al. 2004, Sullivan et al. 2005) and the elderly (Holick 2007). Young 
adults have been shown to have an equal to greater risk of vitamin D insufficiency than 
older people (Tangpricha et al. 2002). Further, food fortification with vitamin D has been 
reported to result in only a minor effect in adolescent Finnish females (Lehtonen-
Veromaa et al. 2008).  
 
Naturally, the vitamin D intake needed to raise the level to 75nmol/l is dependent on 
basal 25(OH)D concentrations (Bischoff-Ferrari 2007) and on calcium status (Heaney 
2008). One study recommended at least 1000IU of vitamin D daily and an adequate 
amount of sun exposure for everyone to combat against vitamin D deficiency (Holick 
2008). A vitamin D3 dose of 3,800IU for those with serum levels above 55nmol/l of 
25(OH)D and a dose of 5,000IU for those below that threshold have been proposed 
(Aloia et al. 2008). Another study showed that administration of vitamin D3 of 400IU for 
eight weeks would elevate the serum 25(OH)D by 11nmol/l (Barger-Lux et al. 1998), 
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while 4,000IU daily are needed to raise 88% of healthy young adults to at least 75nmol/l 
(Vieth et al. 2001). The recent Institute of Medicine recommendations for daily dietary 
intake of vitamin D 600-800IU for adults are purely based on bone benefits (Institute of 
Medicine 2010) and they are very low compared to Bischoff-Ferrari et al. 
recommendations of oral doses of 1800 to 4000IU vitamin D daily which are based on 
other health benefits and higher necessary serum 25(OH)D levels (Bischoff-Ferrari et al. 
2010). 
  
It has been estimated that the body can use up to 5,000IU of vitamin D daily (Heaney et 
al. 2003). In addition, vitamin D supplementation has not been found to be toxic at daily 
doses below 10,000IU (Hathcock et al. 2007). Hypercalcaemia has been suggested to 
be a risk associated with synthetic vitamin D analogues or from calcium components of 
supplements combining calcium and vitamin D (Rhein 2009, Quinton et al. 2009). Large 
doses have been used in vitamin D deficient subjects and it has been shown that a 
loading dose of 500,000IU and then 50,000IU monthly are a safe way to normalize 
25(OH)D levels (Bacon et al. 2009). A recent study reported that for subjects with 
severe vitamin D deficiency, a single oral dose of 300,000IU raises mean 25(OH)D 
levels above 75nmol/l at three months (von Restorff et al. 2009). It has been shown that 
mean serum calcium levels are not related to oral vitamin D at doses up to 100 000IU 
per day or achieved serum 25(OH)D up to 643nmol/l (Bischoff-Ferrari et al. 2010). 
  
Several reasons have been proposed to explain the high prevalence of vitamin D 
deficiency. Both the capacity of the skin to synthesise the previtamin (MacLaughlin et al. 
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1985) as well as the expression of the vitamin D receptor decreases with age (Bischoff-
Ferrari et al. 2004, Venning 2005). In addition, less time spent outdoors (van der Wielen 
et al. 1995) and covering the skin with clothes (El-Hajj Fuleihan et al. 2001) lead to 
decreased exposure to UVB radiation. Seasonal fluctuations in 25(OH)D3 
concentrations have been observed (Lawson et al. 1979, Dawson-Hughes et al. 1997). 
Low 25(OH) levels in winter have been associated with increased PTH levels, bone 
resorption, the proportion of falls resulting in fracture and the frequency of hip and wrist 
fracture (Pasco et al. 2004). 
 
2.6.2 Functions of calcium 
 
Calcium is important for numerous cellular functions including cell division, cell adhesion 
and plasma membrane integrity, protein secretion, muscle contraction, neuronal 
excitability, glycogen metabolism and coagulation (Favus et al. 2008). In addition, it is 
essential for bone formation (Dawson-Hughes 2008). 
 
The concentrations of total calcium in normal serum generally range between 2.12 and 
2.62nmol/l. The maintenance of the serum calcium is regulated by ion transport in the 
kidney, intestinal tract and bone. Low 1,25(OH)D3 levels and PTH stimulate the 
osteoclasts to resorb bone, which leads to calcium release into the extracellular fluid. 
Though several other hormones and clinical conditions can stimulate distal renal tubular 
calcium reabsorption, PTH is an important hormone in this respect (Bushinsky et al. 
1998, Favus et al. 2008). 1,25(OH)D3 enhances intestinal calcium absorption 
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(Bushinsky et al. 1998) and the malabsorption of calcium only occurs at very low levels 
of 25(OH)D (Need et al. 2008). However, an elevation in PTH levels and calcium 
malabsorption can evoke a major increase in bone turnover (Need et al. 2008). 
Therefore, vitamin D insufficiency will have direct effects on bone histology (Need et al. 
2008).  
 
Vitamin D has been reported to have a calcium sparing effect (Steingrimsdottir et al. 
2005). Calcium intake greater than 800mg daily might be unnecessary to adequate 
calcium metabolism if vitamin D status is ensured (Steingrimsdottir et al. 2005). This 
could be explained by improved calcium absorption at higher 25(OH)D levels 
(Steingrimsdottir et al. 2005). Indeed, vitamin D sufficiency has been shown to be more 
important than a high calcium intake in the maintenance of adequate levels of serum 
PTH (Steingrimsdottir et al. 2005). Interestingly, vitamin D status and its associated 
benefits are also believed to be dependent on sufficient calcium intake (Heaney 2008). 
The Institute of Medicine recently recommended a daily dietary intake of calcium 1000-
1200mg for adults (Institute of medicine 2010). However, the recent American Society 
for Bone and Mineral research statement concluded that beneficial effects of calcium 
are achieved at relatively low doses (American Society for Bone and Mineral Research 
2010). There are few findings indicating that calcium supplementation without co-
administered vitamin D would be associated with adverse cardiovascular events (Pentti 
et al. 2009, Bolland et al. 2010). In addition, elderly individuals and subjects with renal 
impairment have been reported to be at a higher risk of suffering cardiovascular 
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problems if they are taking calcium supplements (American Society for Bone and 
Mineral Research 2010). 
 
Hypercalcemia occurs generally when the influx of calcium from the bone or intestine 
exceeds the renal calcium excretory capacity (Bushinsky et al. 1998). Growth, 
pregnancy, primary hyperparathyroidism and sarcoidosis increase intestinal calcium 
absorption (Favus et al. 2008). Hypocalcemia occurs when calcium loss from the 
extracellular fluid is greater than can be replaced by absorption from the intestine or 
bone (Bushinsky et al. 1998). Vitamin D deficiency, chronic renal insufficiency, aging 
and excess glucocorticoids decrease calcium absorption (Favus et al. 2008).  
 
2.6.3 Vitamin D is associated with muscle function 
 
Vitamin D receptor is present in skeletal muscle (Simpson et al. 1985). Vitamin D has 
been reported to exert both genetic and non-genetic effects on muscle function 
(Bischoff-Ferrari et al. 2004, Campbell et al. 2006). First, 1,25(OH)D3 binds to a nuclear 
vitamin D receptor (VDR). This leads to direct gene transcription and de novo protein 
synthesis (Boland et al. 1986). Second, the binding of 1,25(OH)D3 on VDR activates 
certain second-messenger pathways, resulting in enhanced calcium uptake through 
calcium channels in the cell membrane (Campbell et al. 2006).  
 
Recent findings have been shown that vitamin D levels are associated with muscle 
power and force in adolescent girls (Ward et al. 2009). Previously higher 25(OH)D 
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levels have been associated with improved lower extremity function in the elderly 
(Bischoff-Ferrari et al. 2004) and consistently low levels were linked with reduced 
physical performance (Wicherts et al. 2007). Serum levels of 25(OH)D of 80 - 100nmol/l 
are believed to be most advantageous for lower extremity strength (Bischoff-Ferrari et 
al. 2004, Wicherts et al. 2007). Doses of 400IU of vitamin D and 1000mg of calcium 
carbonate for elderly women have been found to be ineffective in combatting against a 
decline of physical functioning (Brunner et al. 2008) since this dose is not sufficient to 
elevate vitamin D to the desirable level, as discussed earlier. However, vitamin D 400IU 
and calcium 800mg have been reported to improve gait speed and body sway and 
training to improve muscle strength in vitamin D deficient subjects (Bunout et al. 2006). 
Whereas, doses of vitamin D 800IU and calcium 1000mg have been reported to 
improve muscle function in community-dwelling older individuals (Bischoff-Ferrari et al. 
2003, Pfeifer et al. 2009).  
 
2.6.4 How does vitamin D prevent falling? 
 
Frailty in older adults has been shown to increase with age and it has been associated 
with incident falls (Fried et al. 2001). Most falls in the elderly result from trips or slips, 
when the impaired balance of an elderly individual prevents swift corrective action 
(Campbell et al. 2005). During sudden movements, the fast and strong type II muscle 
fibers react first to avoid falling (Pfeifer et al. 2002). In osteomalacic patients, the type II 
fibers are believed to become atrophied (Yoshikawa et al. 1979), and myopathy has 
been associated with osteomalacia (Skaria et al. 1975). Low vitamin D status causes 
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muscle weakness, which may lead to further falls (Pun et al. 1990). The fact that 
primarily type II fibers are affected might explain the falling tendency of vitamin D 
deficient subjects (Pfeifer et al. 2002). In fact, vitamin D2 supplementation has been 
shown to increase the diameter of fast twitch type II muscle fibers (Sato et al. 2005). To 
be exact, vitamin D deficiency affects predominantly the weight-bearing muscles of the 
lower limb (Mingrone et al. 1999, Campbell & Allain 2006). Consistently, improved 
25(OH)D status has been associated with better lower-extremity function in the elderly 
(Bischoff-Ferrari et al. 2004) and patients with low 25(OH)D levels have been shown to 
have impaired functional performance, psychomotor function, muscle strength and 
increased falling tendency (Dhesi et al. 2002). Vitamin D has been reported to improve 
neuromuscular function (Glerup et al. 2000, Bischoff et al. 2003, Bischoff-Ferrari et al. 
2004) and balance (Pfeifer et al. 2000). The treatment effect of vitamin D and calcium 
supplementation has been reported to be attributable to improvements in postural and 
dynamic balance (Bischoff-Ferrari et al. 2006) and reduced body sway (Pfeifer et al. 
2000). In one other trial, once a week vitamin D supplementation did not reduce medio-
lateral sway (Lips et al. 2010). It is noteworthy that severe hypovitaminosis D myopathy 
may appear before there are any signs of decreased bone mass (Glerup et al. 2000). In 
addition to the myopathy, vitamin D deficiency has been shown to induce neuropathy 
(Skaria et al. 1975). Vitamin D insufficiency has further been associated with abnormal 
development and functioning on the central nervous system (Tuohimaa et al. 2009). 
This could have some influence on coordinative muscle function.  
 
The subsequent elevation in the PTH level is a consequence of low vitamin D intake. A 
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recent study revealed that PTH has a lesser effect upon muscle function (Ward et al. 
2009) and this has been supported by earlier studies (Bischoff et al. 2003, Sambrook et 
al. 2004). However, there are also conflicting findings of the independent role of PTH in 
proximal myopathy (Chou et al. 1999). 
 
Low 25(OH)D level has been associated with increased fall incidence (Dhesi et al. 
2002, Bischoff et al. 2003). Vitamin D supplementation has been shown to reduce the 
risk of falling by 14-22% in ambulatory and institutionalized elderly (Bischoff-Ferrari et 
al. 2004, Kalyani et al. 2010). In a recent meta-analysis, supplemental vitamin D in a 
daily dose of 700-1000IU decreased the risk of falling by 19% among older subjects 
(Bischoff-Ferrari et al. 2009). The institutionalized elderly women who experience 
recurrent falls (Bishoff-Ferrari et al. 2003) and ambulatory less physically active women 
(Bischoff-Ferrari et al. 2006) have been suggested to benefit most from 
supplementation. Combined vitamin D and calcium supplementation have been shown 
to be superior to calcium alone in reducing the number of falls (Pfeifer et al. 2009). In 
addition, adequate calcium intake has been suggested to be necessary to achieve 
optimal vitamin D action (Kalyani et al. 2010). However, alphacalcidol has been shown 
to reduce number of elderly fallers when the minimum daily calcium intake was only 
500mg (Dukas et al. 2004). 
 
2.6.5 Effect of vitamin D and calcium on bone loss 
 
Calcium and vitamin D are needed for bone growth in children and adolescents as well 
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as to decrease bone loss in adults and the elderly (Dawson-Hughes 2008). Bone loss 
has been suggested to be different in the axial and peripheral skeleton (Hansen et al. 
1995). Hip bone loss has been reported to increase during the last years of life 
(Greenspan et al. 1994, Ensrud et al. 1995). 
  
A close relationship between vitamin D status and BMD has been shown (Mezquita-
Raya et al. 2001, Bischoff-Ferrari et al. 2004). Pubertal girls with hypovitaminosis D 
have been shown to have a risk of not achieving maximum peak bone mass (Lehtonen-
Veromaa et al. 2002). A recent study indicated that serum 25(OH)D is a more important 
predictor of hip BMD than calcium intake (Biscohoff-Ferrari et al. 2009). Resolution of 
vitamin D insufficiency seems to result in a rapid increase in BMD (Adams et al. 1999). 
However, conflicting results about vitamin D status and bone health have also been 
reported (Garnero et al. 2007). One study reported a positive effect of vitamin D and 
calcium fortified dairy products on BMD though no effect was found with calcium alone 
(Moschonic et al. 2006). In early postmenopausal women with adequate vitamin D 
levels, calcium alone has been shown to be as effective as vitamin D (Cooper et al. 
2003).  
 
Healthy postmenopausal and elderly women who have a low calcium intake have been 
reported to benefit from suffering bone loss if they are given calcium supplementation 
(Dawson-Hughes et al. 1990, Elders et al. 1991, Chevalley et al. 1994, Storm et al. 
1998). However, calcium supplementation has been reported to have only a minor 
effect against cortical bone loss but no effect on trabecular bone loss (Riis et al. 1987). 
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The minor effect of calcium supplementation on bone loss has been later confirmed in 
the elderly (Riggs et al. 1998), on bone density in healthy children (Winzenberg et al. 
2006) and prepubertal girls (Bonjour et al. 1997). However, calcium has been also 
claimed to result in a reduction of bone loss and turnover in healthy postmenopausal 
women (Reid et al. 2006). 
 
In a meta-analysis, calcium alone and calcium with vitamin D3 have been associated 
with reduced bone loss at the hip and spine (Tang et al. 2007). In a more recent review, 
it was speculated that calcitriol might have been able to reduce or even reverse bone 
loss in postmenopausal women (Peppone et al. 2010). In another study, the effect was 
non-significant with 400IU of vitamin D3 and 1000mg of calcium at the spine as well as 
in the total body (Jackson et al. 2006). However, a positive result with 560IU of vitamin 
D3 and 1000mg of calcium on spinal BMD has also been reported (Baeksgaard et al. 
1998). Dawson-Hughes et al. claimed that 500mg of calcium and 700IU of vitamin D3 
supplementation had no effect on proximal femur of postmenopausal women who were 
living in the community (Dawson-Hughes et al. 1997). However, an increase of femoral 
BMD during a shorter 18 months follow-up has also been reported with 1200mg of 
calcium and 800IU of vitamin D3 (Chapuy et al. 1992) and the positive effects of 400IU 
vitamin D3 supplementation on femoral BMD have been confirmed in the elderly women 
(Ooms et al. 1995). Chapuy et al. detected a lower rate of annual bone loss at the 
proximal femur in 1200mg of calcium and 800IU of vitamin D3 supplemented ambulatory 
institutionalized women (Chapuy et al. 2002) but 1000IU vitamin D2 had no effect on 
bone (Zhu et al. 2008). Another study showed that in patients with a low-energy 
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fracture, 1400IU of vitamin D3 and 3000mg of calcium could decrease bone loss (Hitz et 
al. 2007). These conflicting findings could be partly explained by variations in dosages 
and different intervals between dosing (Chel et al. 2008). In addition, different forms of 
vitamin D (Richy et al. 2005) and the heterogeneity of study populations, including 
variations in baseline nutritional calcium intake and estrogen status, might have 
confounded the results. 
 
In postmenopausal women, it has been reported that there is reduced loss of total body 
BMD after supplementation (Dawson-Hughes et al. 1997) but some studies have 
reported negative results in younger study populations (Hunter et al. 2000, Patel et al. 
2001). The effect against bone loss in total body (Dawson-Hughes et al. 1997) might be 
explained by effect of calcium and vitamin D on endocortical and cortical bone loss 
(Nordin et al. 1985, Riis et al. 1987, Daly et al. 2006) since the skeleton has a higher 
proportion of cortical than trabecular bone.  
 
Vitamin D supplementation has been shown to be effective against wintertime bone loss 
in healthy postmenopausal women (Dawson-Hughes et al. 1991). The effect of vitamin 
D and calcium supplementation against seasonal bone loss has been reported also in 
healthy adults (Meier et al. 2004). 
 
2.6.6 Vitamin D and calcium on fracture prevention 
 
The muscle weakness, which is associated with vitamin D deficiency, (Glerup et al. 
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2000) may increase fracture risk by causing greater susceptibility to falls (Bischoff et al. 
2003, Visser et al. 2003, Sharkey et al. 2003). In addition, the protective effect of 
vitamin D on fractures has been attributed to the benefits of vitamin D on calcium 
homeostasis and BMD (Ooms et al. 1995, Dawson-Hughes et al. 1997). Furthermore, 
the decreased fracture incidence seen after vitamin D treatment has been proposed to 
be due to improvements in bone quality, which are not measurable by standard DXA, 
and/or in the ability of the neuromuscular system to prevent falls (Heikinheimo et al. 
1996). The reason for decreased fracture incidence with vitamin D and calcium 
supplementation is still a matter of intense debate (Bischoff-Ferrari et al. 2009, The 
Dipart Group 2010). 
 
Low 25(OH)D levels have been associated with a higher risk for hip fracture (Cauley et 
al. 2008) and osteoporotic fractures (van Schoor et al. 2008). A meta-analysis revealed 
that vitamin D supplementation could lower the risk of hip fracture by 26% and any 
nonvertebral fracture by 23% (Bischoff-Ferrari et al. 2005). Daily dose of more than 
400IU of vitamin D reduced nonvertebral fractures in community-dwelling subjects by 
29% and in institutionalized elderly by 15% according to a recent meta-analysis 
(Bischoff-Ferrari et al. 2009). And it was concluded that nonvertebral fracture prevention 
with vitamin D was dose dependent (Bischoff-Ferrari HA et al. 2009). However, some 
trials have not found any effect on fractures of vitamin D, or vitamin D combined with 
calcium (Grant et al. 2005, Porthouse et al. 2005, Jackson et al. 2006). The negative 
results have been explained in part by poor compliance and the low dose of vitamin D 
supplement (Bischoff-Ferrari 2007). In fact, in a trial with better compliance, the hip 
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fracture risk was reduced by 29% (Jackson et al. 2006). A recent meta-analysis found 
that calcium and vitamin D together, but not vitamin D alone could reduce hip fractures 
(The Dipart Group 2010). However, that study was not adjusted for compliance which 
may explain the contrasting conclusions between it and the Bischoff-Ferrari et al. meta-
analysis.  
 
Several factors have been identified to improve adherence in clinical trials (Brunner et 
al. 2009). Intermittent higher doses of vitamin D applied by intra-muscular injection or 
orally may increase adherence (Bischoff-Ferrari 2007). However, daily administration of 
800IU of vitamin D3 has been reported to be more efficient than 100 000IU every four 
months in its ability to elevate the serum 25(OH)D concentration (Pekkarinen et al. 
2010). A dose of 100 000IU of vitamin D orally every four months over five years was 
effective at preventing hip, wrist or forearm and vertebral fractures, an effect was 
achieved without evoking any adverse effects (Trivedi et al. 2003). Furthermore, annual 
intramuscular injections have been shown to prevent fractures in the upper limb 
(Heikinheimo et al. 1992). Surprisingly, it was reported that a single annual dose of 500 
000IU of cholecalciferol resulted in an increased risk of falls and fractures in the first 
three months following dosing (Sanders et al. 2010). 
 
It has been concluded that increased calcium intake alone is not able to reduce the risk 
of hip fracture (Bischoff-Ferrari et al. 2007, Reid et al. 2006, Reid et al. 2008), although 
conflicting results also exist (Tang et al. 2007). 
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2.6.7 Vitamin D is associated with a variety of diseases 
 
The mechanism of 1,25(OH)D3 actions makes it essentially a hormone (Fraser 1995, 
Lee et al. 2008) and in fact 1,25(OH)D3 has been shown to directly or indirectly regulate 
over 200 genes (Holick 2007). 
 
Earlier findings have associated vitamin D deficiency with a 30-50% increased risk of 
colorectal, breast and prostate cancer, (Garland et al. 1985, Ahonen et al. 2000, Grant 
2002, Giovannucci et al. 2006, Jenab et al. 2010), and depression (Gloth 3rd et al. 
1999) and pre-eclampsia (Bodnar et al. 2007). However, serum 25(OH)D levels do not 
seem to be associated with the risk of prostate cancer (Travis et al. 2009). A daily dose 
of at least 400IU of vitamin D was reported to reduce the risk of oesophagus and 
pancreas cancer and non-Hodgkin lymphoma (Giovannucci et al. 2006) and also over 
40% reductions in the risks of multiple sclerosis (Munger et al. 2004) and rheumatoid 
arthritis (Merlino et al. 2004). Subjects who are living at higher latitudes and are at risk 
of vitamin D deficiency have increased risk of type I diabetes (Stene et al. 2000), 
multiple sclerosis (Embry et al. 2000, Ponsonby et al. 2002), hypertension (Rostand 
1997) and schizophrenia (McGrath et al. 2002). Low 25(OH)D levels have been 
associated with a cognitive decline in elderly population (Llevellyn et al. 2010). Recent 
findings have pointed to a role for vitamin D in innate immunity (Walker et al. 2009) and 
preventing upper respiratory tract infections (Ginde et al. 2009). Furthermore, vitamin D 
deficiency has been associated with increased risk of myocardial infarction (Scragg et 
al. 2007, Wang et al. 2008), ischemic stroke and heart failure (Scragg et al. 2007), 
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cardiovascular (Dobnig et al. 2008), cerebrovascular death (Kilkkinen et al. 2009) and 
all-cause death (Virtanen et al. 2010). The association of 25(OH)D levels with all-cause 
and cancer mortality is conflicting (Melamed et al. 2008, Hutchinson et al. 2010, 
Michaëlsson et al. 2010, Freedman et al. 2010). It has been concluded that most of the 
evidence indicated that an improvement in vitamin D status could have a significant 
impact on lowering risk for peripheral vascular and cardiovascular disease (Holick 
2010). 
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3 STUDY AIMS AND HYPOTHESES 
 
The first aim of the present study was to determine whether relatively simple and 
clinically applicable physical tests could be useful in the prediction of bone density in 
postmenopausal women. Poor functional status has been claimed to associate with 
injurious falls and consequent fractures. Accordingly, the second aim was to clarify the 
association between physical tests and fractures.  
 
Vitamin D deficiency is common in the elderly, and it has been associated with many 
health problems. The third and fourth aims were to determine if vitamin D and calcium 
supplementation could prevent falls and bone loss in the ambulatory general population 
of postmenopausal women. 
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4 SUBJECTS AND METHODS 
 
4.1 Study design and subjects 
 
The present thesis was based on Kuopio Osteoporosis Risk Factor and Prevention 
study (OSTPRE) and its substudy OSTPRE Fracture Prevention Study (OSTPRE-FPS). 
The OSTPRE study began in Kuopio, Finland, in 1989. At the baseline in 1989, the 
target population was 14,220 Caucasian women born in 1932-41 and living in the 
Kuopio province, Eastern Finland (Honkanen et al. 1991) (Figure 1). 
 
   
Figure 1. OSTPRE and OSTPRE-FPS studies 
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The OSTPRE-FPS was an open-label RCT with 3-year duration conducted during 2003-
6. The primary aim of the OSTPRE-FPS was to determine whether vitamin D and 
calcium supplementation would be effective for fall and fracture prevention in 
postmenopausal women over the age of 65. The OSTPRE-FPS population (n=3,432) 
was randomly selected from the population-based OSTPRE cohort. The inclusion 
criteria for OSTPRE-FPS were the age at a minimum of 65 years at November 30th 
2002, living in Kuopio province at the onset of the trial and not belonging to the 
OSTPRE bone density measurements sample (n=5,407). The Ethics Committee of 
Kuopio University Hospital approved the OSTPRE-FPS study in October 2001. The 
willingness to participate in a calcium and vitamin D trial was enquired via a postal 
enquiry from August to December 2002. The 3,432 willing women (63.5%) were 
randomized into two groups of equal size without blocking or stratification or random 
allocation sequence by an independent statistician. The subjects were informed their 
groups by postal notification according to the randomization. The intervention and 
control groups had 1,718 and 1,714 subjects, respectively. Two random samples were 
selected from these groups and they included 375 out of 1,718 and 375 out of 1,714 
ambulatory women. These two samples formed the subsample (n=750) of this study. 
This subsample underwent detailed measurement program including functional 
capacity, serum 25(OH)D and BMD measurements (Figure 1). 
 
The studies I, III and IV were conducted on the OSTPRE-FPS and the study II on the 
original OSTPRE cohort. 
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Figure 2. Flowchart of the OSTPRE-FPS trial (grey area denotes the OSTPRE-FPS subsample) 
Eligible subjects of 
OSTPRE-cohort (n = 5407) 
1975 Excluded 
    701 Did not return enquiry 
    962 Not willing to participate 
    312 Did not meet inclusion           
criteria 
237 Withdrew after 
randomization 
  132 From intervention group 
      132 Withdrew consent 
  105 From control group 
      83 Withdrew consent 
      15 Died before start 
      7 No contact information 
3432 Randomized 
   1718 to intervention group 
   1714 to control group 
 
1296 Allocated to calcium + 
vitamin D group and received 
allocated intervention 
1296 Allocated to control 
group 
17 Lost to follow-up 
    12 Died 
    5 Contact lost 
180 Discontinued intervention 
    Reasons: 
        96 Adverse Effects 
       81 Other Reasons 
        3 No reason 
29 Lost to follow-up 
    12 Died 
    7 Not willing to continue 
    4 Not able to continue 
    6 Contact lost 
Intention to treat –analysis 
1279 Analyzed  
   
Intention to treat –analysis 
1267 Analyzed  
     
290 313 
3 
3 
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17 
22 
1 
7 
1 
1 
1 
4 
287 
     
306 
    
Randomly selected subsamples 
    375/1718 to intervention 
group  
    375/1714 to control group 
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4.2 Postal enquiries 
 
4.2.1 OSTPRE (Study II) 
 
The postal enquiry included questions about health disorders, medication, use of 
hormone therapy (HT), gynecological history, nutritional habits including calcium intake, 
physical activity, alcohol consumption, smoking and anthropometry. At the 5-year 
follow-up in 1994, and subsequently at the 10-year follow-up in 1999 and the 15-year 
follow-up in 2004, questionnaires similar to those used at the OSTPRE baseline were 
sent to the 12,831, 12,562 and 12,075 women, respectively, who had responded to the 
first inquiry (n=13,100) and were alive at the time of enquiry. Responses were obtained 
from 11,954, 11,538 and 10,926 women at the five, ten and fifteen years follow-up, 
respectively. Thus, the response rate varied between 90-92%.  
 
4.2.2 OSTPRE-FPS (Studies I, III and IV) 
 
The OSTPRE-FPS baseline enquiry was sent to all who consented to participate in 
2003. The enquiry information was updated from those women who had undergone 
bone densitometry measurements. In addition, regular exercise in the last twelve 
months (hours per week) was inquired with a form that listed the most popular physical 
activities and the duration of activity. The subjects had also a possibility to name an 
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activity which was not listed. The physical activity questionnaire form was designed for 
the OSTPRE-FPS. 
 
4.3 Vitamin D and calcium intervention (Studies III and IV) 
 
The intervention group received daily cholecalciferol 800 IU and calcium carbonate 
1000 mg supplementation (Calcichew-D3 Forte, Leiras-Nycomed Ltd) divided into two 
daily doses for three years and the control group received no supplementation. The 
vitamin D and calcium was a combined formula in a chewable dosage form which the 
subjects took twice a day. Both groups were asked to continue with their previous diet. 
The supplements were distributed via prescriptions, which were written and supervised 
by the author of the study, and local pharmacies arranged the distribution of the 
supplements. The prescriptions were written for a one-year period at the beginning of 
the trial. The pharmacies had to contact the research team once a year in order to 
renew the prescriptions. The pharmacies provided the supplements for 3 months at a 
time for the subjects of the intervention group. Compliance was calculated as the 
percentage of the delivered tablets out of the predicted consumption during the follow-
up period. 
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4.4 Physical tests 
 
4.4.1 Grip strength (Studies I and II) 
 
Grip strength (GS (kg)) of the dominant hand was measured using three successive 
repetitions with a Jamar hand dynamometer in OSTPRE-FPS study (Sammons Preston 
Rolyan, Cedarburg, WI, USA). A hand-held pneumatic squeeze dynamometer (Martin 
Vigorimeter, Tuttlingen, Germany) was used in the OSTPRE study. The elbow was 
flexed at a 90° angle and not allowed to contact any body part. Resting time between 
subsequent measurements was 30 seconds. The mean value of the two best 
performances was used in the analyses. The intraclass correlation coefficient (ICC) of 
the grip strength measurements has been shown to be 0.87 for absolute grip strength 
values (Sirola et al. 2006). 
 
4.4.2 Standing on one foot (Studies I and II) 
 
The subject was asked to perform a one leg stand (seconds) on the dominant foot for a 
maximum of 30 seconds with the eyes open. The weight-bearing foot was not allowed 
to move and the hands were placed on the waist. Two attempts were allowed and the 
longer of the two performances was recorded. The reliability coefficient for this test has 
previously been reported to be 0.85 (Giorgetti et al. 1998). 
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4.4.3 Quadriceps isometric extension strength (Studies I and II) 
 
Quadriceps isometric extension strength (Nm) of both legs was measured by sitting in a 
leg extensor bench (Metitur Oy, Jyväskylä, Finland) with the femoral region in a 
stabilized position and the knee joint flexed at 65° at the beginning of a steady maximal 
isometric extension movement. For isometric quadriceps force, the coefficients for 
variation have been reported to be 13-19% depending on the knee movement angle 
(Robertson et al. 1998). Extension strength was measured three times from both legs 
with a 30 second rest period after each measurement. Mean values for each side were 
calculated using the two best performances. These were summed up to form a 
combined lower limb value. 
 
4.4.4 Squatting (Studies I and II) 
 
The subject was asked to squat down (succeeded: yes/no) vertically in a stable position 
and to keep her feet in place, hands straight on side, not to move, touch the floor with 
her fingers and then to rise up again. A moderate reliability for squatting test has been 
reported previously (Alaranta et al. 1994).  
 
4.4.5 Standing with eyes closed (Study I) 
 
Standing in the normal posture (succeeded: yes/no) was tested, with hands on the 
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waist, both feet on the ground and eyes closed for 10 seconds. The ICC for the test has 
been reported to be 0.69 (Emery et al. 2005). 
 
4.4.6 Tandem walk and fast regular walk (Study I) 
 
A tandem walk with hands placed on waist for six meters along a dotted line and a fast 
regular walk for a ten meter distance were performed. The women were asked to 
perform one practice before the proper measurement was done and the time of walking 
was measured (seconds). The ICC inter-rater reliability for the tandem walk test has 
been reported to be >0.88 (Rinne et al. 2001) and the test-retest reliability of the fast 
regular walk >0.95 (Steffen et al. 2002). 
 
4.4.7 Chair rising test (Study I) 
 
The number of repetitions in chair rising without the help of hands in 20 seconds was 
measured. The test-retest reliability (ICC) of the chair rising test has been reported to be 
0.83 (Simmonds et al. 1998). 
 
4.4.8 Vision (Study II) 
 
The vision was measured with the standard E-board. The distance between the board 
and the subject was five meters. The subject had both eyes open and glasses were 
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allowed. She was asked to tell the first and the last mark on the line until she was 
unable to distinguish smaller characters. The subject was asked to enumerate the 
whole line, if there were errors, she was asked to read the previous line. The line where 
subject was able to see three letters out of five correct was recorded as the vision ability 
in dioptres.  
 
4.4.9 Self-assessed ability to move (Study II) 
 
The self-assessed ability to move (n=9,466) was obtained from the subject's self-report 
in OSTPRE 5-year questionnaire. This was divided into four categories, "full ability to 
walk and run", "ability to walk but unable to run", "walking ability maximum of one 
kilometer" and "walking ability maximum of one hundred meter".  
 
4.5 Bone mineral density measurement (Studies I and IV) 
 
BMD measurements in the OSTPRE-FPS were performed at the lumbar spine (L2-L4), 
left proximal femur and total body with DXA (Lunar Prodigy, GE, Madison, WI, USA). 
The regions of interest at the proximal femur included femoral neck, trochanter, Ward's 
triangle and total proximal femur. The quality control of the DXA instruments was run 
daily. The in vitro long-term reproducibility (CV) for total femur region was 0.3%. 
Technical quality of each DXA measurement and analysis was carefully checked and 
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those with measurement errors were not included in the statistical analyses. 
 
4.6 Falls (Study III) 
 
The falls were defined according to the ICD10 disease classification including the 
categories W00-W03 (fall on same level), W10 (fall on stairs) and R29.6 (tendency to 
fall). The participants in the subsample were telephoned initially four months after the 
baseline measurement and then at four month intervals to record the incidence and 
circumstances of falls, any resulting injuries and whether the fall was so serious that it 
required medical attention. The rest of the trial population was interviewed by phone 
once a year between January and April during the trial. 
 
4.7 Fractures (Study II) 
 
The follow-up time for fractures started at the five-year measurement of the OSTPRE 
study (1994-1997) and lasted until the 1st of October 2004 if no fracture was recorded. 
The total duration of follow-up varied from 6.4 to 9.9 (mean 8.4) years. Fractures due to 
high-energy trauma, e.g. motor vehicle and bicycle crash, falls from above the ground 
level and pathological process were excluded. Follow-up fractures were recorded based 
on ten-year and fifteen-year follow-up questionnaires. The women were questioned 
about whether they had suffered a fracture during the preceding 5-year period and its 
type, mechanism and treatment. All self-reported fractures were validated by cross-
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checking with radiological reports. However, in cases where a rib fracture was reported, 
the diagnosis was also accepted based on clinical assessment without radiological 
proof. The self-reported fractures in the OSTPRE-study have been previously validated 
(Honkanen et al. 1999). Fracture history was recorded from the OSTPRE baseline to 
the 5-year measurement.  
 
4.8 Statistical analyses 
 
All statistical analyses were carried out using the Statistical Package for Social 
Sciences (version 14.0.1; SPSS, Chicago, IL) for Windows. In the cross-sectional study 
(I), analyses were performed with multivariate linear regression and two-way ANOVA 
models. Receiver operator characteristics (ROC) curves and the corresponding area 
under the curve (AUC) were used to evaluate how well physical tests could predict 
osteoporosis. The analyses were adjusted for age (years), body mass index (BMI) 
(cm/m2), years of HT, years since menopause, a dichotomous current smoking (yes/no) 
and the use of oral glucocorticoids. 
 
In the cohort study (II), Cox regression analyses were used to analyze the ability of 
physical tests to predict future fractures during 8-year follow-up. The results were 
expressed as hazard ratios (HR) with 95% confidence intervals (95% CI). The analyses 
were adjusted for age, BMI, years of HT, years since menopause, current smoking 
status (yes/no) and fracture history (yes/no). 
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In the RCT study (III) data was analysed on intention-to-treat (ITT) basis by retaining 
allocation to groups according to randomization and by including all subjects with 
endpoint information. The primary outcomes were the women with falls and women with 
falls requiring medical attention. The posthoc analyses included multiple falls and 
multiple falls requiring medical attention. The proportion of individuals falling in 
intervention vs. control group was analysed with the risk ratios (RR). The risk (OR) of 
falling was analysed with logistic regression, in which the dependent variable was either 
a person with 0 vs. one with 1+ falls or a person with 0-1 falls vs. one with 2+ falls.  
 
In the RCT study (IV) data was analysed on the ITT basis by retaining allocation to 
groups according to randomization. The change in BMD inside the group was defined 
with paired samples t-test. The change of BMD between the groups was defined with 
general linear repeated measures model (GLM). All analyses were un-adjusted. 
 
The change in physical capacity between the RCT intervention and control groups was 
analysed with the GLM. The GLM analyses included the baseline and the end-point 
measurements of the physical capacity tests. The association between the physical 
capacity tests and the falls was assessed with logistic regression. 
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5.1 Characteristics of the study population 
 
Table 2. Baseline characteristics of the 2928 OSTPRE women in 1994 (Study II) 
—————————————————————————————————————————— 
Characteristics 
 
 
Age (SD)    
  
59.1 (2.9) 
Weight (kg) (SD)  
  
72.1 (13.2) 
Height (cm) (SD)  
  
160.0 (5.7) 
Years postmenopausal (SD)  
                         
6.7 (5.0) 
Use of hormone therapy (years) (SD) 
                         
2.6 (3.5) 
Smoker at baseline, n (%)  
                         
269 (9.1) 
Previous fracturea, n (%)  
                         
363 (12.3) 
Grip strength (Nm) (SD) (n=2904) 
                         
68.0 (18.0) 
Isometric knee extension strength (kg) (SD) 
(n=1767)  
                        
31.6 (11.6) 
Vision (dioptre) (SD) (n=1822) 
  
1.2 (0.3) 
Ability to squat down (%) (n=2885)  
                         
96.0 
Ability to squat down to the floor (%) (n=2809) 
 
74.7 
Standing-on-one-foot at least 10 seconds 
(%)(n=2844) 
——————————————————————————————————— 
93.0 
 
—————— 
a wrist 103/3.5%, ankle 58/2.0%, clinical vertebral 20/0.7%, hip 6/0.2% and all other fractures 176/6.0% 
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Table 3. Baseline characteristics of the subsample (n=593) and the entire study population 
(n=3139) of the OSTPRE-FPS in 2004 (Studies I, III and IV). 
 Subsample (n=593) Entire study population (n=3139) 
Characteristic 
Intervention 
group 
(n=306) 
 
Control group 
(n=287)  
Intervention group 
(n=1566)  
Control group 
(n=1573) 
        
Age (years) 67.4 (2.0)  67.4 (1.9)  67.4 (1.9)  67.3 (1.8) 
Weight (kg) 70.3 (12.3)  69.9 (10.3)  70.7 (12.4)  70.8(11.5) 
Height (cm) 160 (5.3)  160 (5.1)  160 (5.3)  160 (5.3) 
BMI (kg/m2) 27.5 (4.5)  27.4 (3.9)  27.7 (4.6)  27.7 (4.4) 
        
        
Age at menopause (years) 49.3 (5.3)  49.4 (4.6)  49.3 (4.7)  49.6 (4.5) 
Years since menopause 18.1 (5.7)  18.1 (5.2)  18.2 (5.0)  17.8 (5.0) 
History of HT-use (%)        
  Users 52.9 %  56.5 %  52.3 %  52.4 % 
        
Duration of HT-use (years) 10.6 (6.6)  11.4 (7.6)  10.5 (6.9)  10.3 (7.4) 
        
Use of calcium supplements 15.0 %  19.0 %  16.2 %  18.0 % 
        
Calcium/milk products 
(mg/day) 928 (487)  888 (490)  892 (472)  892 (472) 
Calcium/supplements 
(mg/day) 310 (179)  319 (180)  321 (191)  312 (187) 
Calcium total (mg/day) 988 (490)  965 (489)  952 (485)  961 (482) 
        
Number of prescribed 
medications 2.8 (2.6)  2.5 (2.5)  2.7 (2.6)  2.6 (2.6) 
        
Alcohol doses/week 0.7 (1.5)  0.8 (1.4)  0.8 (1.5)  0.8 (1.5) 
        
Alcohol doses/week (%)        
  no alcohol 52.3 %  45.6 %  48.7 %  49.9 % 
  <1 doses / week 22.0 %  24.9 %  23.6 %  22.9 % 
  1 – 4.9 doses / week 23.8 %  26.2 %  25.0 %  24.4 % 
  5 – 9.9 doses / week 1.4 %  3.4 %  2.3 %  2.3 % 
  >= 10 doses /week 0.5 %  0.0 %  0.5 %  0.4 % 
        
Smoking status (%)        
  Current smoker 6.2 %  3.6 %  4.8 %  5.5 % 
        
Physical activity level (hours) 11.0 (10.8)  12.4 (12.8)  -  - 
        
Self-assessed physical 
ability 1        
  Capable of running 41.5 %  55.7 %  48.0 %  51.1 % 
  Capable of walking 49.6 %  36.3 %  42.8 %  39.5 % 
  Walking max 1000 m 6.0 %  6.0 %  6.4 %  7.3 % 
  Walking max 100 m 1.8 %  1.3 %  1.8 %  1.5 % 
  Walking indoors 1.1 %  0.7 %  0.9 %  0.5 % 
  Unable to walk 0.0 %  0.0 %  0.1 %  0.1 % 
        
Bone mineral density 
Femoral neck (g/cm2) 0.866 (0.132)  0.866 (0.120)  -  - 
L2-L4 (g/cm2) 1.082 (0.189)  1.096 (0.190)  -  - 
        
Serum 25(OH) level 50.0 (18.7)  49.1 (17.7)  -  - 
        
 1 The difference was statistically significant at the p=0.01 level in the subsample. 
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5.2 Physical tests and osteoporosis (Study I) 
 
Table 4. Association (r2) between physical tests and osteoporosis 
Physical test Lumbar Femoral Trochanter Total proximal 
  spine neck  femur 
————————————————————————————————————————— 
Standing on one foot (s) 0.161 0.172 0.202 0.232 
Grip strength (Nm) 0.161 0.161 0.192 0.211 
Squat down  - 0.151 0.191 0.211 
 
1 The association was statistically significant at the p<0.05 level 
2 The association was statistically significant at the p<0.001 level 
 
Standing on one foot (SOOF) was associated with lumbar spine (r2=0.16, p=0.004), femoral 
neck (r2=0.17, p < 0.001), trochanter (r2=0.20, p < 0.001) and total proximal femur BMD 
(r2=0.23, p < 0.001). The grip strength (GS) was associated with lumbar spine (r2=0.16, 
p=0.011), femoral neck (r2=0.16, p=0.002), trochanter (r2=0.19, p < 0.001) and total proximal 
femur BMD (r2=0.21, p=0.004). The ability squat down to floor was associated with the femoral 
neck (r2=0.15, p=0.031), trochanter (r2=0.19, p=0.040) and total proximal femur BMD (r2=0.21, 
p=0.028). 
 
According to the ROC analyses, identifying women at risk of osteoporosis using a threshold of 
22kg in GS would yield a true-positive rate (sensitivity) of about 58%, but there would be a 
false positive rate (1-specificity) of 14%. This means that a total of 58% of the women with 
osteoporosis would be included into this group, and only 14% who were predicted to have 
osteoporosis would not be suffering from this disease.  A threshold of 16 seconds in the SOOF 
test would yield a true-positive rate of about 67% and a false positive rate of 40%. A less 
stringent threshold would identify more women with osteoporosis, but would increase the rate 
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of overdiagnosis. 
 
The subjects were divided into normal/osteopenic and osteoporotic groups according to the T-
score of the femoral neck and lumbar spine BMD (WHO classification). Osteoporotic women, 
according to femoral neck, performed significantly worse in SOOF (p=0.001), GS (p<0.001), 
leg extension strength (p=0.007), ability to squat down to floor (p=0.004) and tandem walk for 
6 meters (p=0.014). According to the lumbar spine BMD, SOOF (p=0.032), GS (p=0.005) and 
leg extension strength (p=0.037) were significantly worse in osteoporotic subjects. 
 
5.3 Physical tests and fractures (Study II) 
 
Table 5. Associations (HR with 95% CI) between physical tests and fractures 
————————————————————————————————————————— 
Physical test Hip fracture Clinical vertebral All fractures 
————————————————————————————————————————— 
Inability to stand on  
one foot for 10 seconds 9.11 (1.98-42.00) 2 -  - 
Grip strength  
(per 1Nm decrease) 1.05 (1.01-1.09) 1 -  - 
Knee extension strength 
(per 1kg decrease) -  -  1.02 (1.00-1.03) 1 
Ability to walk less 
than 100 meters 11.57 (2.73-49.15) 2  3.85 (1.45-10.22) 2 - 
 
1 The association was statistically significant at the p<0.05 level 
2 The association was statistically significant at the p<0.01 level 
 
The inability to SOOF for 10 seconds increased the risk of subsequent hip fracture (HR with 
95% CI, significance) 9.11-fold (1.98-42.00, p=0.005). Decreased grip strength associated with 
1.05-fold (1.01-1.09, p=0.026) increased risk of hip fractures. Low leg extension strength 
associated with 1.02-fold (1.00-1.03, p=0.013) higher risk for all fractures. The HRs are 
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estimated per one Newton meter and one kg decrease in grip and leg extension strength, 
respectively. No significant relationships were found between physical tests with wrist and 
ankle fractures. The self-assessed ability to walk less than 100 meters increased the risk of 
ankle fractures by 2.36-fold (1.10-5.08, p<0.05), hip 11.57-fold (2.73-49.15, p<0.01) and 
clinical vertebral fractures by 3.85-fold (1.45-10.22, p<0.01). 
 
5.4 Vitamin D and calcium supplementation and falls (Study III) 
 
Table 6. The effect (OR with 95% CI) of daily vitamin D 800IU and calcium 1000mg 
supplementation on falls and falls requiring medical attention 
————————————————————————————————————————— 
Endpoint  Entire trial population Subsample 
  (n=3139)  (n=593) 
————————————————————————————————————————— 
Falls  1.05 (0.91-1.20) 0.82 (0.58-1.14) 
Multiple falls 1.13 (0.97-1.32) 0.70 (0.50-0.97) 1 
Falls requiring medical 
attention  0.84 (0.70-1.01) 0.93 (0.66-1.31) 
Multiple falls requiring 
medical attention 0.72 (0.53-0.97) 1 0.82 (0.49-1.37) 
 
1 The odds ratio was statistically significant at the p<0.05 level  
 
In the entire trial population (n=3139), a total of 1645 subjects with 3776 falls were recorded. 
There were 812 (out of 1566, 52%) women experiencing 1832 falls in the intervention group 
and 833 (out of 1573, 53%) women with 1944 falls in the control group (risk ratio (RR) for the 
number of fallers was 0.98, 95% CI 0.92-1.05, p=0.160). In the logistic regression model 
(subject with none or one fall versus subject with two or more falls), the results were also 
statistically non-significant (odds ratio (OR) 1.13, 95% CI 0.97-1.32, p=0.113). The comparison 
of those individuals with no falls versus individuals with a fall was statistically non-significant 
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(OR 1.05, 95% CI 0.91-1.20, p=0.536). 
 
A total of 384 subjects experiencing 954 falls were recorded during the three year follow up in 
the subsample (n=593). There were 179 (out of 287, 62%) women with 430 falls in the vitamin 
D and calcium supplementation group and 205 (out of 306, 67%) women with 524 falls in the 
control group (RR 0.82, 95% CI 0.73-0.92, p=0.032). In the logistic regression model (an 
individual with none or one fall versus an individual with two or more falls), the multiple fall 
incidence decreased by 30% in the supplementation group (OR 0.70, 95% CI 0.50-0.97, 
p=0.034). In the comparison of those subjects with no falls versus subjects with at least one 
fall, the results were statistically non-significant (OR 0.82, 95% CI 0.58-1.14, p=0.239). 
 
In the entire trial population (n=3139), a total of 557 subjects with 821 falls requiring medical 
attention (FRMA) were recorded. There were 258 (out of 1566, 16%) women with 377 FRMA 
in the intervention group and 299 (out of 1573, 19%) women with 444 FRMA in the control 
group. In the logistic regression model (a subject with none or one FRMA versus a subject with 
two or more FRMA), the FRMA incidence decreased by 28% in the supplementation group 
(OR 0.72, 95% CI 0.53-0.97, p=0.031). Comparing individuals with no FRMA versus 
individuals with FRMA, the results were statistically non-significant (OR 0.84, 95% CI 0.70-
1.01, p=0.063). 
 
A total of 201 subjects with 301 FRMA were recorded during the three-year follow up in the 
subsample (n=593). There were 95 (out of 287, 33%) women with 142 FRMA in the vitamin D 
and calcium supplementation group and 106 (out of 306, 35%) women with 159 FRMA in the 
control group. In the logistic regression model (a subject with none or one FRMA versus a 
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subject with two or more FRMA), the results were statistically non-significant (OR 0.82, 95% CI 
0.49-1.37, p=0.443). The comparison of those subjects with no FRMA versus subjects with 
FRMA was statistically non-significant (OR 0.93, 95% CI 0.66-1.31, p=0.692). 
 
5.5 Vitamin D and calcium supplementation and bone loss (Study IV) 
 
Table 7. The effect (percentage change) of daily vitamin D 800IU and calcium 1000mg 
supplementation with adherent women on bone loss  
————————————————————————————————————————— 
Study group Spine Femoral Trochanter2Proximal Total body1 
  (L2-L4) 2 neck2  femur2 
————————————————————————————————————————— 
Intervention (%) 0.67 -1.26 0.25 -0.84 1.31 
Control (%)  0.76 -1.73 -0.88 -1.47 0.19 
 
1 The difference was statistically significant at the p<0.05 level 
2 The difference was statistically significant at the p<0.01 level 
 
Total body BMD increased significantly more in the intervention group than in the control group 
(0.84% vs. 0.19%, p=0.011). The BMD decrease at the Ward’s triangle was lower in the 
intervention group (-2.69% vs. -2.83%, p=0.003). The BMD changes at the spine (p=0.372), 
femoral neck (p=0.188), trochanter (p=0.085) and total proximal femur (p=0.070) were 
statistically non-significant between the groups. 
 
The women who were adherent (i.e. those who took at least 80% of their supplementation) 
showed significantly lower bone loss in femoral neck (-1.26% vs. -1.73%, p=0.002), Ward’s 
triangle (-1.63% vs. -2.83%, p<0.0001), trochanter (0.25% vs. -0.88%, p=0.001) and total 
proximal femur (-0.84% vs. -1.47%, p<0.0001) than the control group. Further, total body BMD 
increased more in the intervention group (+1.31% vs. +0.19%, p=0.002). In contrast, lumbar 
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spine bone loss was greater in the intervention group than in the control group (+0.67% vs. 
+0.76%, p=0.033). 
 
5.6 Vitamin D and calcium supplementation and physical capacity 
 
There were no statistically significant changes in the physical capacity tests between the study 
groups. Furthermore, the physical capacity did not change differently in subjects with a single 
or multiple falls (Table 8). 
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Table 8. Physical capacity during three year trial in intervention (n=306) and control (n=287) 
groups in the subsample of the OSTPRE-FPS and difference of change between the groups 
(p-value; GLM-test) 
————————————————————————————————————————— 
Physical capacity test 
Baseline, 
mean (SD) 
3-years, 
mean (SD) p-value 
    
Grip strength, kg   0.211 
Intervention group 26.0 (5.1) 25.0 (5.9)  
Control group 26.6 (7.4) 25.0 (5.3)  
    
Standing on one foot, seconds  0.059 
Intervention group 19.2 (10.5) 16.7 (11.3)  
Control group 18.5 (10.5) 17.6 (10.9)  
    
Ability to squat down to floor, yes/no  0.477 
Intervention group 0.7 (0.5) 0.7 (0.5)  
Control group 0.7 (0.5) 0.7 (0.5)  
    
Standing with eyes closed 10 seconds, yes/no  0.861 
Intervention group 0.9 (0.2) 1.0 (0.2)  
Control group 1.0 (0.2) 1.0 (0.2)  
    
Chair rising test, number of repetitions  0.279 
Intervention group 8.0 (4.4) 8.4 (3.2)  
Control group 7.9 (2.7) 8.7 (3.1)  
    
Tandem walk 6m, seconds  0.971 
Intervention group 18.7 (7.7) 18.5 (13.7)  
Control group 19.7 (8.7) 19.4 (10.9)  
    
Regular walking 10m, seconds  0.236 
Intervention group 6.4 (1.9) 6.5 (3.0)  
Control group 6.1 (1.5) 6.8 (2.5)  
    
Right leg extension strength, Nm   0.828 
Intervention group 304.2 (79.3) 275.8 (73.1)  
Control group 297.0 (78.6) 267.3 (69.6)  
    
Left leg extension strength, Nm   0.324 
Intervention group 287.3 (77.7) 265.4 (69.1)  
Control group 290.9 (85.3) 262.7 (70.0)  
————————————————————————————————————————— 
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5.7 Physical capacity tests and falls 
 
Standing-on-one-foot time was associated with a decreased risk for falls (individual with no 
falls versus individual experiencing a fall) (OR for one sec. increase 0.98, 95% CI 0.97-0.99, 
p=0.026). Further, the standing-on-one-foot test was associated with multiple falls (individual 
with no falls or one fall versus individual with two or more falls) (OR for one sec. increase 0.98, 
95% CI 0.96-0.99, p=0.005). 
 
5.8 Compliance and adverse effects of the supplementation (Studies III and IV) 
 
The mean compliance for vitamin D and calcium supplementation was 78%. The numbers for 
70%, 80% and 90% compliance were 77.4%, 74.2% and 69.1% of the intervention group 
(entire trial population), respectively. 
 
A total of 220 out of 1586 women discontinued the intervention, 113 due to adverse effects, 
103 due to other reasons and four did not give any specific reason. The most common 
adverse effects causing discontinuation were gastrointestinal symptoms (64 cases out of the 
entire intervention population, 1586), nausea (12 out of 1586) and skin reactions (9 out of 
1586). Gastrointestinal symptoms included abdominal pain and heartburn. Other reasons for 
discontinuation the study included: not willing to continue intervention, pharmacy stopped 
intervention delivery, fear of interactions, onset of illness, not willing or capable to visit 
pharmacy, primary health care physicians decision, bad taste of tablets, tablets difficult to 
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swallow, fear of accumulation of calcium, considered that she was receiving sufficient calcium 
and vitamin D from other sources, fear of orange flavour, considered tablets as placebo and 
participation in another trial. 
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6 DISCUSSION 
 
6.1 Methodological considerations 
 
6.1.1 Study population 
 
The target population at baseline in 1989 was all of the 14,220 Caucasian women born in 
1932-41 and living in the Kuopio province in Eastern Finland. The response rates to the 
OSTPRE postal enquiries were high (90-92%). Thus the OSTPRE cohort represents fairly well 
the target population.  
 
The study population in studies I, III and IV originated from the OSTPRE-FPS. The cohort in 
study II was from the OSTPRE. The 5,407 subjects were selected from the original OSTPRE 
cohort to participate in the OSTPRE-FPS and the 3,432 volunteers (63.5%) were included. 
Consequently, the population-based benefit was diminished. With this limitation, the 
generalization of the results of the studies III and IV to the Caucasian female population over 
the age of 65 years might still be justified. 
 
Participation in the trial might have resulted in over-representation of healthier women in 
OSTPRE-FPS study. This was also confirmed, since in the loss analysis, the subjects, who left 
the study between the randomization and beginning of the trial, were heavier, with higher BMI, 
used less HT and alcohol but more cigarettes, and had poorer self-assessed physical capacity. 
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In all, 3.8% of control subjects reported using prescribed vitamin D with or without calcium 
supplements at the baseline, but this has risen to 16.1% by the end of the trial. This, in 
combination with a mean compliance in the calcium plus vitamin D group of 78%, may have 
decreased the difference in calcium and vitamin D intake between the groups, and weakened 
the power to detect a difference. Adherence rates of less than 60% have been suggested to be 
insufficient to achieve a fracture prevention effect (Bischoff-Ferrari et al. 2007). In addition, 
large trials with vitamin D for the prevention of fractures among older persons indicate that only 
about 50% of older individuals adhere to a daily oral vitamin D supplement (Grant et al. 2005, 
Porthouse et al. 2005). Accordingly, the compliance of 78% of the present study might be 
considered as acceptable and high enough to reveal any positive effect of vitamin D and 
calcium supplementation. To sum up, younger age, healthier study population, incomplete 
compliance and increased supplementation use in the control group as well as relatively high 
nutritional calcium intake and serum 25(OH)D levels may have jointly decreased the size of 
the effect in this study. 
  
6.1.2 Study design 
 
Study I was cross-sectional which means that no conclusions can be drawn about causal 
relationships. Its purpose was to find diagnostic tools for osteoporosis. Study II was an 
observational epidemiological study which may have uncontrolled confounding. However, 
population-based study sample may diminish confounding. 
 
Studies III and IV were randomized controlled trials (RCT). The RCT studies are reputed to 
54
  
represent the highest grade in the hierarchy of research designs (Benson et al. 2000, Concato 
et al. 2000). However, OSTPRE-FPS was an open trial and neither placebo control nor 
blinding was applied. The reason for blinded assessment and placebo is to prevent biased 
reporting. It could be that subjects in the intervention group of study III recalled falls more 
completely since they were more intensively involved in the trial. This could have lead to 
differential misclassification resulting in underestimation of the effect. However, the average 
time of phone contacts was similar in both groups, which should have decreased the 
differential recall. The results were also consistent between the falls in general and falls 
requiring a medical attention which support the validity of the findings. 
 
The OSTPRE-FPS a priori power calculations were conducted based on fracture incidence 
from an earlier Swedish study (Kanis et al. 2001). Accordingly, the primary endpoint of the 
OSTPRE-FPS study was a fracture. However, the statistically significant results in studies III 
and IV reveal to some extent that there was a sufficient sample size also for the secondary 
endpoints.  
 
The follow-up time of three years in OSTPRE-FPS was long enough to detect both fall and 
BMD endpoints. However, with respect to fractures, a follow-up period of five years could have 
been better since the fracture incidence remained rather low in the present study. 
 
6.1.3 Measurements and collection of outcome events 
 
All physical capacity and muscle strength tests in the study I were first carefully explained and 
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demonstrated to the subjects and the performance was controlled by specially trained 
personnel. Grip strength measurement was the only physical test that was validated in our 
cohort (Sirola et al. 2006). However, the validity of physical tests has been shown to range 
from good to moderate in earlier studies (Alaranta et al. 1994, Giorgetti et al. 1998, Robertson 
et al. 1998, Simmonds et al. 1998, Rinne et al. 2001, Steffen et al. 2002, Emery et al. 2005, 
Sirola et al. 2006). 
 
The BMD measurements in the studies I and IV were performed at the lumbar spine (L2-L4), 
left proximal femur and total body with DXA (Lunar Prodigy, GE, Madison, WI, USA). Errors 
due to measurement technique were minimized by using specially trained personnel and by 
regular use of phantom measurement controls.  
 
Follow-up fractures in study II were recorded based on OSTPRE ten-year and fifteen-year 
follow-up questionnaires. The women were questioned about whether they had suffered a 
fracture during the preceding 5-year period and its type, mechanism and treatment. All self-
reported fractures were validated by cross-checking with radiological reports. The validity of 
self-reports of fractures in OSTPRE study in general has been previously assessed (Honkanen 
et al. 1999). 
 
The inadequacy of infrequent (annual) fall assessment in study III is illustrated by the higher 
fall rate documented in the subset of 593 subjects in whom falls were assessed every 4 
months compared with the other subjects in whom falls were assessed annually. Even in the 
subsample, a phone call every 4 months without a diary or a postcard note on each fall may 
have limitations. It has been reported that the amount of time elapsing between the exposure 
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and the recall is an important indicator of the accuracy of recall (Rothman et al. 1998). 
However, previously used reporting methods (Graafmans et al. 1996, Bischoff-Ferrari et al. 
2003) might not have had as good adherence in a population-based study. Since fall reporting 
is based on self-assessment, it is virtually impossible to achieve the same kind of accuracy as 
with fracture reporting. The problem with fall reporting is that most falls do not cause any 
injury, and thus they are soon forgotten. It has been recognized that recall of falls has only 
limited accuracy (Cummings et al. 1988, Kanten et al. 1993). The placebo controlling might 
have increased the validity of self-reported falls. Use of medical records for fall validation might 
not confer any additional validity since the reason for hospital visits might not have been fully 
recorded. The falls requiring medical attention were also used since one could argue that this 
outcome will have been more completely reported than falls in general. The observed odds 
ratios were probably closer to the null than would have been the case if the recall bias had 
been absent. Although there are limitations in fall reporting, it is believed that the pragmatic 
approach of community-based intervention has advantages compared with earlier studies 
which have limited generalization to the overall women population over the age of 65 years. 
 
6.2 Physical tests and osteoporosis 
 
In study I, BMD associated with SOOF, GS and ability squat down to floor. It has been shown 
that it is worthwhile to recommend BMD testing to women aged 65 or older or younger 
postmenopausal women who have a strong or multiple risk factors for suffering fracture (US 
Preventive Services Task Force 2002). However, most individuals with osteoporosis remain 
undiagnosed and untreated (Kiebzak et al. 2002, Gehlbach et al. 2002, Morris et al. 2004). 
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Several clinical risk factors for low bone mass have been found; these include female sex, 
increased age, estrogen deficiency, white race, low weight and BMI, family history of 
osteoporosis, smoking and history of prior fracture (National Institutes of Health 2001, Rosen 
2005, Kanis et al. 2008). Different risk factors have been combined to form risk assessment 
tools and these have been further evaluated (Cadarette et al. 2001, Gourlay et al. 2008). 
However, none of these have included physical performance as a clinical risk factor for 
osteoporosis. 
 
BMD is an intermediate endpoint. Furthermore, BMD measurements cannot identify those 
subjects who will suffer a fracture (Marshall et al. 1996). Fracture outcome could be 
considered more clinically important. Physical capacity tests reflect indirectly on 
neuromuscular function as muscle force, muscle power and balance, are all contributive 
factors for falls and fractures. Bone medications are used throughout the world to prevent 
fractures in patients with osteoporosis (Liberman et al. 1995, Saag et al. 1998, Recker et al. 
2004). Accordingly, associations between physical capacity tests and osteoporosis might help 
clinicians to objectively determine which patients should be further evaluated for osteoporosis 
and fracture prevention.  
 
There were 22 (4%) and 61 (12%) subjects suffering from osteoporosis of the femoral neck 
and lumbar spine, respectively. In a Swedish population sample, the prevalence of femoral 
neck osteoporosis in the same age group has been 20% (Kanis et al. 2000). Accordingly, the 
low number of osteoporotic subjects in this present study might indicate that this was a 
healthier population cohort. Further, the low absolute number of osteoporotic subjects might 
have caused some of the analyses to remain underpowered to be able to detect statistically 
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significant results. 
 
Unexpectedly, BMD of the lower limb was not associated with leg extension strength or chair 
rising test. Previously, neuromuscular performance has been shown to independently 
associate with bone strength (Rantalainen et al. 2010). However, femoral BMD was associated 
with SOOF and ability in the squat down to floor tests which measures not only muscle 
strength but also balance and coordinative muscle function. Based on this finding, it could be 
postulated that coordinative muscle function and muscle power of the lower limbs might be 
associated with BMD rather than muscle strength alone. In addition, the changes in muscle 
strength with age have been shown to differ between different muscle groups (Rantanen et al. 
1997). 
 
Previously, it has been shown that spinal motion performance declined and functional 
impairment increased in relation to the severity of bone loss (Tsauo et al. 2002). Osteoporosis 
has been associated with back and functional impairment, which further affected the quality of 
life (Tsauo et al. 2002, Fechtenbaum et al. 2005). The questionnaire about the back pain, 
physical test which measures lower back mobility and their association with osteoporosis will 
need to be assessed in more detail in future studies. 
 
BMD measurements can be used to estimate quantity of bone. In addition to quantity, bone 
quality is an important determinant of the fracture risk (Stokstad 2005, Seeman et al. 2006). In 
the future studies, one further focus might be to clarify possible associations between bone 
geometry, structure and muscle performance. 
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6.3 Physical tests and fractures 
 
In study II, the decreased GS, low leg extension strength, inability to SOOF 10 seconds and 
self-assessed ability to walk less than 100 meters were associated with future fractures. It has 
been shown that half (Sanders et al. 2006) or even more than half (Pasco et al. 2006) of 
fragility fractures in women over the age of 50 occur in women without osteoporosis. Even if 
one considers subjects suffering the classical “osteoporotic” fractures (hip, Colles and 
vertebral) then only 59% have osteoporosis (Sanders et al. 2006). Accordingly, other clinical 
risk factors in addition to BMD provide supplemental insight into the prevention of fractures 
(Taylor et al. 2004, Kanis et al. 2007). However at present, clinical risk factors do not include 
physical capacity measurement (Kanis et al. 2008) although grip strength has been shown to 
predict fractures in perimenopausal women (Sirola et al. 2006, Sirola et al. 2008). The WHO 
fracture risk assessment tool FRAXTM is based on individual patient models that integrate the 
risks associated with clinical risk factors but it does not include the physical capacity. The 
important risk factors for hip and wrist fractures apparently are related to bone strength and 
falls (Nevitt et al. 1993, McClung et al. 2001). Thus, the associations between physical 
capacity and fractures could provide new methods for the fracture prevention in the future. 
 
In women who have experienced a fall, limitations in mobility have been shown to increase the 
risk for future falls by 4 to 15-fold (Mänty et al. 2010). Falls are an important external cause of 
fractures to distal radius (Vogt et al. 2002, Honkanen 1995), proximal humerus (Kristiansen et 
al. 1987) and hip (Hayes et al. 1993). Accordingly, the risk for fracture-related falls has been 
studied. Slow gait speed, difficulties in tandem walk and poor vision (Dargent-Molina et al. 
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1996, Taylor et al. 2004), impaired physical function (Formiga et al. 2008), balance (Wagner et 
al. 2009) and self-reported health and physical activity (Robbins et al. 2007) have been 
associated with hip fractures. Low lower limb strength may increase the relative risk for by falls 
ten fold (Carter et al. 2001). However, subjects in study II were rather young since their mean 
baseline age was 59. In this population, wrist and ankle fractures were the most common. 
Falls and BMD have been associated with wrist fractures (Vogt et al. 2002, Honkanen et al. 
1995) and lifestyle factors (i.e. smoking and obesity) with ankle fractures (Valtola et al. 2002). 
It might be that people who are more active sustain more often falls and subsequently 
fractures. On the other hand, it might be that the nature of the fall is an important predictor of 
these fractures. For example, subjects with poor physical capacity might have poorer 
protective responses to falling. In fact, a fall to the side and impairment in mobility are 
important risk factors for hip factures in osteoporotic elderly individuals (Greenspan et al. 
1998). In addition, obese subjects might have a higher fall impact owing to body weight. 
 
Frailty in older adults as defined by unintentional weight loss (10 lbs in past year), self-reported 
exhaustion, muscle weakness (grip strength), slow walking speed, and low physical activity, 
have all been shown to increase with age (Fried et al. 2001). In women over the age of 60, the 
risk of fracture has been shown increase by 6% per year (Pasco et al. 2006). Accordingly, 
frailty and its increasing prevalence during aging obviously is important in osteoporosis as well 
as in fall and fracture risk. 
 
Hand grip strength has been shown to be an indicator of overall muscle strength and it may 
predict mortality via mechanisms other than those leading from disease to muscle impairment 
(Rantanen et al. 2003). Furthermore, grip strength and SOOF were associated with lumbar 
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spine BMD in study I but these tests were not associated with clinical vertebral fractures in 
study II. Although femoral BMD is more strongly related to most of the fracture types than 
spinal BMD in the elderly (Stone et al. 2003) spinal BMD has been shown to be independently 
related with vertebral fractures (Cauley et al. 2007). Bending and lifting activities have been 
shown to generate loads on the spine that in very low BMD can exceed the failure load (Myers 
et al. 1997). That may be that reason why some part of vertebral fractures might have been 
not due to a fall and therefore increasing muscle strength in an attempt to avoid the falls has 
not been meaningful. In fact, spinal BMD might be a better indicator for fall related fracture risk 
in younger people (Honkanen et al. 1995).  
 
In the study population of early postmenopausal women, it is likely that there are some 
comorbid neurological or muscular conditions or other issues that may increase fracture risk 
for those who cannot stand on one foot for 10 seconds or who have hip fractures. However, 
comprehensive adjustment for known confounders (age, BMI, years of HT, years since 
menopause, current smoking status and fracture history) was used to minimize bias caused by 
those factors. One limitation was that there were only eight hip fractures in this relatively young 
group of women.  
 
 A history of prior fracture is a strong risk factor for future fractures, an over and above that can 
be explained by variations in BMD (Kanis et al. 2004). Mortality after low-trauma fracture has 
been associated with quadriceps weakness and subsequent fracture (Bliuc et al. 2009). In 
addition, the disability following fractures has been studied (Fink et al. 2003). Accordingly, 
there might possibly be causality between physical capacity, fractures and mortality. 
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6.4 Vitamin D and calcium supplementation and falls 
 
It was found that vitamin D and calcium supplementation was effective in preventing multiple 
falls. This finding is supported by Bischoff et al. who have demonstrated previously that 
recurrent fallers benefit most from this kind of treatment (Bischoff et al. 2003). As discussed 
above, study III had the possible limitation on some degree of non-accurate self-reporting of 
falls. However, this study is the first to demonstrate the effective role of vitamin D and calcium 
supplementation on injurious fall in a general population women aged 65 to 71. 
 
Previous studies about the effect of vitamin D and calcium supplementation on falls have been 
conducted in the very elderly or institutionalised subjects (Bischoff et al. 2003, Bischoff-Ferrari 
et al. 2004, Pfeifer et al. 2009). However, even in the very elderly, some studies have been 
negative (Burleigh et al. 2007). The low prevalence of very low 25(OH)D levels have been 
used as an explanation for the lack of association between falls and vitamin D levels 
(Pramyothin et al. 2009). Another study detected the most pronounced effect in less physically 
active women (Bischoff-Ferrari et al. 2006). 
 
In future studies, the effect of a higher vitamin D dose might reveal additional benefit for fall 
prevention. It might be that the present dose was not sufficient to reveal all potential to muscle 
performance. One could argue that especially vitamin D was the key nutrient since the mean 
nutritional calcium in present population intake was sufficient. According to the recent 
American Society for Bone and Mineral research statement the beneficial effects of calcium 
occur at relatively low doses (American Society for Bone and Mineral Research 2010). Thus, 
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the need for additional calcium supplementation in addition to the nutritional supply of 1000mg 
should be examined critically. 
 
6.5 Vitamin D and calcium supplementation and bone loss 
 
It was found that bone loss in ambulatory women could be decreased by vitamin D and 
calcium supplementation. There is consistent evidence that vitamin D deficiency can evoke 
accelerated bone loss in elderly subjects (Krall et al. 1989, Dawson-Hughes et al. 1991). The 
effect of vitamin D on improved bone strength and mass has been attributed to lower PTH 
levels and consequently lower stimulus for bone resorption (Mezquita-Raya et al. 2001, 
Dawson-Hughes et al. 2007).  A recent study indicated that only women with 25(OH)D levels 
below 50nmol/l benefits from a higher calcium intake (Bischoff-Ferrari et al. 2009). A meta-
analysis revealed that calcium alone and calcium with vitamin D were associated with reduced 
bone loss at the hip and spine (Tang et al. 2007). 
 
Femoral neck BMD has been reported to fluctuate with the seasons (Dawson-Hughes et al. 
1991). Dawson-Hughes et al. reported that 500mg of calcium and 700IU of vitamin D3 
supplementation had no effect on proximal femur in a three-year follow-up (Dawson-Hughes et 
al. 1997). However, an increase of femoral BMD during a shorter 18 months follow-up has also 
been reported with 1200mg of calcium and 800IU of vitamin D3 (Chapuy et al. 1992). Chapuy 
et al. described a lower rate of annual bone loss at the proximal femur in 1200mg of calcium 
and 800IU of vitamin D3 supplemented subjects (Chapuy et al. 2002) but 1000IU vitamin D2 
treatment had no effects on bone (Zhu et al. 2008). In elderly vitamin D deficient women, the 
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400 IU of vitamin D3 and 500mg of calcium supplementation increased BMD at the lumbar 
spine, femoral region and in total body (Grados et al. 2003). On the other hand, weekly 10000 
IU of vitamin D2 did not have any effect over 1000mg of calcium alone on the early 
postmenopausal BMD (Cooper et al. 2003). The discrepancies in these results highlight the 
problems with different vitamin D dosages, intervals between dosing (Chel et al. 2008), 
different forms of vitamin D (Richy et al. 2005) and variations in study populations. Even the 
vitamin D receptor genotype has been associated with the effect of vitamin D supplementation 
on the BMD of the femoral neck (Graafmans et al. 1997). 
 
An earlier study has shown that calcium supplementation has only a minor effect on the loss of 
cortical bone and no effect on the trabecular bone (Riis et al. 1987). In another study, vitamin 
D supplementation has also been associated with reduced seasonal bone loss at the spine, 
which is mostly trabecular bone (Dawson-Hughes et al. 1991). Furthermore, vitamin D and 
calcium supplementation have decreased the seasonal change in both the spinal and femoral 
BMD (Meier et al. 2004). The age-related decrease in cortical bone density and geometry has 
been reported to lead to decreased bone biomechanical properties (Ito et al. 2010). 
Accordingly, the present finding that vitamin D and calcium supplementation affected total 
body is important since most of the skeleton is constituted of cortical bone. 
 
The rate of bone loss in total hip has been reported to be 0.025g/cm2 per year in women in the 
age group 67-69 years old (Ensrud et al. 1995). In this study, the bone loss in the total hip was 
slightly less, 0.014g/cm2 per three years in both groups. At the beginning of menopause, the 
annual bone loss at the femoral neck has been shown to be as high as -1.8% decreasing to -
0.5% for women who are more than five years after menopause (Pouilles et al. 1995). Another 
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study reported -0.7 to -0.8% annual bone loss rates for different femoral regions (Greenspan et 
al. 1994). This study detected a bone loss of around -2% over three years at the femoral neck 
in both groups, which is similar to many previous studies. 
 
6.6 Vitamin D and calcium supplementation and physical capacity 
 
There were no statistically significant changes in the physical capacity tests between the study 
groups during the trial. Muscle strength is known to decline with age in healthy elderly subjects 
with adequate vitamin D status (Boonen et al. 1998) and vitamin D has not been shown to 
prevent this loss of muscle strength (Grady et al. 1991). However, in vitamin D deficient elderly 
individuals, supplementation can have a positive effect on muscle strength (Janssen et al. 
2002). A trend for better maintained regular walking speed in the supplementation group might 
reflect better preserved lower extremity function. However, the extension strength of the lower 
limbs did not differ between the groups and nor was it associated with falls. The finding that 
the baseline SOOF test, which measures primarily the dynamic balance, was associated with 
subsequent falls is support for this hypothesis. The effect of vitamin D on fall prevention has 
previously been claimed to be mediated through both better postural and dynamic balance 
(Bischoff-Ferrari et al. 2006). However, vitamin D did not improve the SOOF test performance 
in the present study. 
 
Earlier studies have reported both the positive (Bischoff et al. 2003) and negative (Pramyothin 
et al. 2009) effects of vitamin D and calcium supplementation on musculoskeletal function. 
Furthermore, it has also been reported that 25(OH)D levels are not associated with 
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neuromuscular function (Faulkner et al. 2006). Vitamin D supplementation has been increased 
proximal muscle strength in adults with vitamin D deficiency but it has not significantly affected 
muscle strength in adults with baseline 25(OH)D level over 25nmol/l (Stockton et al. 2010). 
The reason why physical capacity parameters were not changed differentially between the 
groups in the present study might be due to the fact that younger and healthier subjects were 
evaluated than in previous studies. The contrast between intervention and control group may 
have been too small due to the open design and increased vitamin D intake in the control 
group. Nonetheless, there were still factors related to potential errors in the physical test 
measurements or in the interpretation of the results (Sirola et al. 2004). The reliability of 
physical tests has been shown to be good to moderate in previous studies but unfortunately 
they were not validated in the present study. However, specially trained personnel were 
recruited to minimize the measurement of uncertainties. Another explanation for the null 
results in the physical capacity might be that possible improvements would have been missed 
in these physical tests. Thus, fast-pace walking speed has been associated with 25(OH)D 
levels and proposed to be a more sensitive marker of neuromuscular functioning compared to 
usual-pace walking (Annweiler et al. 2010). 
 
There is some evidence that the 25(OH)D level threshold for muscle strength benefit may be 
around 40 nmol/l (Bischoff-Ferrari et al. 2004). In addition, an 25(OH)D level below 50nmol/l 
has been associated with increased body sway and a level below 30nmol/l with decreased 
muscle strength (Pfeifer et al. 2002). If this is the case, then a possible explanation for the null 
result is that both groups were close to or even over these thresholds. On the other hand, 
there is earlier evidence that serum 25(OH)D concentrations above 90 to 100nmol/l are best 
for lower extremity strength (Bischoff-Ferrari et al. 2004) and above 75nmol/l for fall prevention 
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(Bischoff-Ferrari et al. 2007). In the present study, the intervention group reached the mean 
25(OH)D level of 74.6nmol/l and accordingly it could explain the decreased incidence of 
multiple falls. However, serum 25(OH)D did not reach a desirable level for the best muscle 
strength benefits. Thus, the weak effect and the negative finding in the entire trial population 
may also be partly due to the low number of severely vitamin D deficient women in this 
ambulatory postmenopausal population. 
 
6.7 Effect of supplementation on serum 25(OH)D levels and adverse effects 
 
The serum 25(OH)D levels rose 24.7 (24.1) nmol/l and 6.8 (19.3) nmol/l in the intervention and 
control groups, respectively. At the end of the trial, the corresponding mean 25(OH)D levels 
were 74.6 (21.9) nmol/l and 55.9 (21.8) nmol/l. As discussed above, a serum level above 
75nmol/l has been claimed to be effective for fall prevention and 90-100nmol/l for adequate 
lower extremity strength. However, even these levels might be not sufficient for fracture 
prevention (Salovaara et al. 2010).    
 
The points discussed above; younger age, healthier study population, incomplete compliance 
and increased supplementation use in the control group as well as relatively high nutritional 
calcium and vitamin D intake, might have affected the achieved serum 25(OH)D levels. It 
should be remembered that over 90% of vitamin D is derived from ultraviolet B light (Pearce et 
al. 2010) and in Finland for over half a year the amounts of sunshine are insufficient for proper 
vitamin D synthesis. The season variation in serum 25(OH)D levels was assessed by taking 
the blood samples in visits that were distributed throughout the calendar year. 
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In OSTPRE-FPS, only 113 out of 1585 women discontinued the intervention due to adverse 
effects. The most common adverse effects were gastrointestinal symptoms, nausea and skin 
reactions. Accordingly, there were not any severe side effects associated with the vitamin D 
and calcium supplementation. 
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7 CLINICAL RECOMMENDATIONS AND CONCLUSIONS 
 
The first aim of the present study was to determine whether relatively simple and clinically 
applicable physical tests could be useful in prediction of bone density in postmenopausal 
women. It is proposed that grip strength could be used in medical decision making to identify 
those women who would benefit from BMD measurements, albeit alone it may not represent 
an accurate enough tool for osteoporosis screening. 
 
Poor functional status has appeared to associate with injurious falls and consequent fractures. 
The second aim was to define association between functional capacity and fractures. 
According to the results, the standing-on-one-foot less than 10 seconds, grip strength and a 
question about ability to walk less than 100 meters may help to predict postmenopausal 
fractures. 
 
Vitamin D deficiency is common in the elderly, and it has been associated with many health 
problems. The third and fourth aims were to determine if vitamin D and calcium 
supplementation could prevent falls and bone loss in ambulatory general population of 
postmenopausal women. Overall, the primary analysis revealed no association between 
calcium and vitamin D supplementation and risk of falls. However, the results of a post hoc 
analysis indicated that the supplementation might decrease the risk of multiple falls requiring 
medical attention. Furthermore, the results indicated that daily vitamin D and calcium 
supplementation have a positive effect on the skeleton in ambulatory postmenopausal women 
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with adequate nutritional calcium intake without any severe side effects. In conclusion, higher 
vitamin D intake can be recommended for the general population of postmenopausal women. 
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In general, the fracture risk is 
highest among those who have 
osteoporotic bone mineral density 
(BMD) but nonetheless most fragility 
fractures occur in subjects who do 
not have osteoporosis. Their poor 
physical condition might predispose 
these individuals both to low BMD 
and a higher risk for fall-related 
fractures. Vitamin D has been 
shown to have also physiological 
importance outside of bone health 
and calcium homeostasis, and there 
is evidence that it plays a role in the 
prevention of falling.
The present thesis was based on 
Kuopio Osteoporosis Risk Factor 
and Prevention study (OSTPRE) 
and its substudy OSTPRE Fracture 
Prevention Study (OSTPRE-FPS).
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